triazoles has been researched along with Body Weight in 213 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (10.80) | 18.7374 |
| 1990's | 18 (8.45) | 18.2507 |
| 2000's | 58 (27.23) | 29.6817 |
| 2010's | 108 (50.70) | 24.3611 |
| 2020's | 6 (2.82) | 2.80 |
| Authors | Studies |
|---|---|
| Ari, C; Brunner, B; D'Agostino, DP; Kovács, Z | 1 |
| Khokhlov, AL; Leykin, ZN | 1 |
| Adrian, TE; Albawardi, A; Almarzooqi, S; Haneefa, S; Hennig, R; Imbaraj, E; Maruta, H; Nemmar, A; Subramanya, S; Zaaba, NE | 1 |
| Bouslama, R; Chi, NW; Dumont, V; Krauss, S; Kuusela, S; Lehtonen, S; Linden, AM; Pirinen, E; Ramadan, UA; Rinnankoski-Tuikka, R; Waaler, J; Wang, H | 1 |
| Alenina, N; Bader, M; Dias-Júnior, NM; Eleutério-Silva, MA; Ferreira-Neves, VP; Moura, FA; Nunes-Souza, V; Rabelo, LA | 1 |
| Bernardo, V; Fernandez, AJ; Liverman, R; Miles, A; Tippett, A; Yildirim, I | 1 |
| Ambhore, SR; Goyal, VK; Londhe, S; Nakka, H; Nirogi, R; Pandey, SK | 1 |
| Benrick, A; Carlström, M; Cushman, SW; Fornes, R; Hu, M; Ivarsson, N; Maciel, GAR; Maliqueo, M; Marcondes, RR; Stener-Victorin, E; Stenkula, KG | 1 |
| Afsar, T; Almajwal, A; Jahan, S; Pirzada, M; Rauf, N; Razak, S; Ullah, A; Ullah, H | 1 |
| Camerino, GM; Cantatore, P; Conte, E; Cormio, A; Fehrentz, JA; Fonzino, A; Fracasso, F; Lezza, AMS; Liantonio, A; Martinez, J; Musicco, C; Pesce, V; Rizzi, L; Sirago, G; Torsello, A | 1 |
| Abdo, M; Fekry, E; Makary, S | 1 |
| Malik, S; Mellon, PL; Ryan, GE | 1 |
| Ahn, JH; Chen, BH; Hwang, IK; Kang, IJ; Kim, DW; Kim, H; Kim, YM; Lee, CH; Lee, JC; Lee, TK; Park, JH; Song, M; Won, MH; Yan, BC | 1 |
| Boudawara, T; Chaâbane, M; Chelly, S; Ellouze Chaabouni, S; Elwej, A; Ghorbel, I; Mnif, H; Soudani, N; Zeghal, N | 1 |
| Abid, A; Afsar, T; Almajwal, A; Jahan, S; Khalid, S; Razak, S; Shaheen, G | 1 |
| Ding, J; Ge, LQ; Wu, JC; Xu, B; Yang, GQ; Zhang, X | 1 |
| Charalambous, C; Havlickova, T; Jerabek, P; Lapka, M; Puskina, N; Sustkova-Fiserova, M | 1 |
| Fukui, K; Nangaku, M; Saito, H; Sugahara, M; Tanaka, S; Tanaka, T; Wakashima, T | 1 |
| Feng, WY; Hu, L; Huang, L; Li, TF; Liu, XM; Luo, XX; Ma, XL; Wu, CF | 1 |
| Bartola, LD; Giampietro, C; Giampietro, O; Masoni, MC; Matteucci, E | 1 |
| Badole, SL; Bagul, PP; Coutinho, EC; Ghule, AE; Jangam, GB; Joshi, AC; Khedkar, VM; Khose, RD; Mahamuni, SP; Raut, CG | 1 |
| Apaijai, N; Chattipakorn, N; Chattipakorn, SC; Pintana, H | 1 |
| Bhargava, A; Del Prato, S; Dharmalingam, M; Garber, AJ; Philis-Tsimikas, A; Rasmussen, S; Satman, I; Skjøth, TV | 1 |
| Caderni, G; Femia, AP; Lodovici, M; Maglieri, G; Mannucci, E; Raimondi, L | 1 |
| Dahooee Balooch, F; Ebrahimpour, R; Fatemi, SJ; Iranmanesh, M | 1 |
| Charbonnel, B; Dejager, S; Schweizer, A | 1 |
| Scheen, AJ | 1 |
| Han, J; Malloy, J; Meloni, A | 1 |
| Du, Q; Liang, YY; Wang, YJ; Wu, B; Yang, S; Zhao, YY | 1 |
| Epstein, S; Gallagher, EJ; Kornhauser, C; LeRoith, D; Sun, H; Tobin-Hess, A; Yakar, S | 1 |
| Badole, SL; Bagul, PP; Chaudhari, SM; Joshi, AC; Khose, RD; Mahamuni, SP; Raut, CG; Zanwar, AA | 1 |
| Canovatchel, W; Davidson, J; Januszewicz, A; Lavalle-González, FJ; Meininger, G; Qiu, R; Tong, C | 1 |
| Chang, G; Duan, Q; Lu, K; Qin, S; Wang, Y; Ye, L; Zhang, D; Zhang, P; Zheng, A | 1 |
| Ajimi, S; Aso, S; Furukawa, K; Hasegawa, R; Hoshuyama, S; Kikuchi, J; Koga, T; Kusune, Y; Miyata, K; Yoshida, T | 1 |
| Alba, M; Canovatchel, W; Cefalu, WT; Edwards, R; Jodar, E; Kim, KA; Meininger, G; Stenlöf, K; Tong, C | 1 |
| Hardy, E; Jabbour, SA; Parikh, S; Sugg, J | 1 |
| Andersén, H; Bohlooly-Y, M; Cottrell, EC; Denn, M; DeSchoolmeester, J; Goldberg, FW; Gutierrez, PM; Harno, E; Leighton, B; Swales, JG; Turnbull, AV; White, A; Wild, MJ; Yu, A | 1 |
| Beckman, DA; DeCristofaro, M; Pouliot, L; Samadfam, R; Schneider, M; Smith, SY | 1 |
| Gallacher, DJ; Hemmeryckx, B; Roger Lijnen, H; Rong Lu, H; Swinnen, M | 1 |
| Cunningham, C; Dey, M; Forest, T; Frederick, C; Holder, D; Prahalada, S; Smith, A; Yao, X | 1 |
| Schnell, O | 1 |
| Belden, JB; Hartman, EA; McMurry, ST; Smith, LM | 1 |
| Coric, J; Dizdarevic-Bostandzic, A; Djelilovic-Vranic, J; Izetbegovic, S; Karamehic, J; Macic-Dzankovic, A; Panjeta, M; Velija-Asimi, Z | 1 |
| Aroor, AR; Garro, M; Habibi, J; Hayden, MR; Johnson, M; Lastra, G; Manrique, C; Meuth, A; Nistala, R; Sowers, JR; Whaley-Connell, A | 1 |
| Funahashi, T; Hayashi, M; Hibuse, T; Hirata, A; Kashine, S; Kimura, T; Kishida, K; Maeda, N; Minami, T; Nakagawa, Y; Nishizawa, H; Oka, A; Shimomura, I; Takeshita, E | 1 |
| Ahrén, B; Cirkel, DT; Feinglos, MN; Johnson, SL; Perry, C; Stewart, M; Yang, F | 1 |
| Gao, Y; Guo, B; Li, J; Li, Y; Liu, C; Lv, X; Wang, H | 1 |
| Guthrie, R; Slee, A; Traina, S | 1 |
| Katakami, N; Matsuoka, TA; Shimomura, I; Shiraiwa, T; Takahara, M | 1 |
| Blayo, AL; Fehrentz, JA; Haluzík, M; Holubová, M; Jurčovičová, J; Lacinová, Z; Maletínská, L; Martinez, J; Moulin, A; Nagelová, V; Stofkova, A; Sýkora, D; Zelezná, B | 1 |
| Baerts, L; Behets, GJ; D'Haese, PC; De Meester, I; Glorie, L; Verhulst, A | 1 |
| Gou, Z; Ma, M; Wang, F; Wang, T; Zhai, SD | 1 |
| Marchesini, G; Melchiorri, D; Montilla, S; Pani, L; Sammarco, A; Siviero, PD; Tomino, C; Trotta, MP | 1 |
| Bailey, RA; Blonde, L; Meininger, GE; Rupnow, MF; Vijapurkar, U | 1 |
| Cellai, L; Corti, F; Dettori, I; Melani, A; Pedata, F | 1 |
| Allshouse, AA; Alvero, R; Casson, PR; Christman, GM; Coutifaris, C; Diamond, MP; Eisenberg, E; Krawetz, SA; Legro, RS; Polotsky, AJ; Santoro, N; Schlaff, WD; Trussell, JC; Zhang, H | 1 |
| Aratsu, Y; Hamada, H; Ishii, Y; Kakutani, M; Kume, S; Nishiu, J; Oda, T; Ohe, Y; Ohta, T; Okuma, C; Oshida, S; Tadaki, H; Taniuchi, H; Yamanaka, K; Yata, S | 1 |
| Couriel, DR; Kauffman, CA; Miceli, MH; Perissinotti, AJ | 1 |
| Birch Petersen, K; la Cour Freiesleben, N; Lauritsen, MP; Pedersen, AT; Pedersen, NG | 1 |
| Lian, Y; Wang, W; Zhao, F | 1 |
| Cao, SF; Hu, WL; Jiang, LY; Wu, MM | 1 |
| Ben Haj Salah, K; Biagini, G; Bresciani, E; Fehrentz, JA; Liantonio, A; Locatelli, V; Martinez, J; Molteni, L; Omeljaniuk, RJ; Ravelli, M; Rizzi, L; Torsello, A | 1 |
| Mahmood, I | 1 |
| Chahoud, I; Gericke, C; Grote, K; Haider, W; Herzler, M; Niemann, L; Selzsam, B | 1 |
| Garcia, PC; Gerardin, DC; Moreira, EG; Pereira, OC; Piffer, RC | 1 |
| Minobe, Y; Shiraishi, K; Umano, T; Yamasaki, K | 1 |
| Drucker, DJ; Duez, H; Giacca, A; Lewis, GF; Smith, AC; Szeto, L; Xiao, C | 1 |
| Davidson, JA; Gross, JL; Parente, EB | 1 |
| Chen, PJ; Hester, SD; Lambert, GR; Moore, T; Nesnow, S; Padgett, WT; Thai, SF; Winnik, W | 1 |
| Adamicova, K; Kajo, K; Kubatka, P; Nosalova, G; Ostatnikova, D; Sadlonova, J; Sadlonova, V | 1 |
| Furukawa, T; Manabe, S; Matsuyama, T; Saitoh, W; Sakurai, K; Sanbuissho, A; Shirai, M; Teranishi, M | 1 |
| Akhtar, S; Benter, IF; Dahly-Vernon, AJ; Dunn, KM; Roman, RJ; Yousif, MH | 1 |
| Mikhail, N | 2 |
| Ema, M; Hirata-Koizumi, M; Hirose, A; Kamata, E; Kawabata, M; Matsuno, K; Matsuyama, T; Yajima, K | 1 |
| De Bock, M; Dobenecker, B; Engelen, M; Goossens, L; Kienzle, E; Scholz, A | 1 |
| Cognard, E; Shepherd, PR; Smith, GC; Vickers, MH | 1 |
| Andreu, E; Fernández, C; Ferrando, MD; Sancho, E; Villarroel, MJ | 1 |
| Ciccarelli, L; Cicero, AF; D'Angelo, A; Derosa, G; Ferrari, I; Franzetti, IG; Gadaleta, G; Maffioli, P; Piccinni, MN; Querci, F; Ragonesi, PD; Salvadeo, SA | 1 |
| Aberdeen, GW; Albrecht, ED; Baschat, AA; Harman, CR; Langenberg, PW; Pepe, GJ; Weiner, CP | 1 |
| Alexander, CM; Siler, SQ; Topp, BG; Waters, SB | 1 |
| Birnbaum, Y; Keyes, KT; Lin, Y; Perez-Polo, JR; Ye, Y; Zhang, C | 1 |
| Arvapalli, RK; Blough, ER; Gadde, MK; Kakarla, SK; Katta, A; Laurino, JP; Paturi, S; Rice, KM; Walker, EM; Wehner, P; Wu, M | 1 |
| Bilo, HJ; Goudswaard, AN; Houweling, ST; Kleefstra, N; Kooy, A; van Hateren, KJ; Verhoeven, S | 1 |
| Lteif, A; Mitre, N | 1 |
| Bilan, VP; Jackson, EK; Tofovic, DS | 1 |
| Davies, MJ; Engel, SS; Mavros, P; Radican, L; Rajagopalan, S; Yin, D; Zhang, Q | 1 |
| Fritzsche, B; Nau, H; Rühl, R; Schmidt, A; Schuchardt, JP; Schweigert, FJ | 1 |
| Clar, C; Cummins, E; Marien, M; Philip, S; Richter, B; Royle, P; Waugh, N | 1 |
| Fernandes, R; Ferreira, L; Garrido, P; Mega, C; Melo, A; Nunes, S; Parada, B; Pinto, F; Pinto, R; Reis, F; Santos, P; Sereno, J; Teixeira, F; Teixeira-de-Lemos, E; Vala, H; Velada, I | 1 |
| Fatemi, SJ; Saljooghi, ASh | 1 |
| Borelli, MI; Del Zotto, H; Flores, LE; Francini, F; Gagliardino, JJ; Madrid, VG; Maiztegui, B; Massa, ML; Raschia, MA; Rebolledo, OR | 1 |
| Coben, J; Dobrian, AD; Galkina, EV; Leone, KA; Lindsay, JW; Ma, K; Ma, Q; Nadler, JL | 1 |
| Borgia, JA; Mufson, EJ; Overk, CR | 1 |
| Anjana, RM; Kishore, U; Mohan, V; Sudhakaran, C; Unnikrishnan, R | 1 |
| Best, JH; Garrison, LP; Li, Y; Malloy, J; Peyrot, M; Rubin, RR; Yan, P | 1 |
| Moore, T; Nesnow, S; Padgett, WT | 1 |
| Christiaens, V; Lijnen, HR; Scroyen, L | 1 |
| Chen, B; Ernsberger, P; Escobedo, LV; Hou, D; Koletsky, MS; Koletsky, RJ; Moore, A | 1 |
| Boor, R; Brandt, C; Jürgens, U; Korn-Merker, E; May, TW; Rambeck, B | 1 |
| Horie, T; Shitara, Y; Tanii, H | 1 |
| Boucheron, JA; Brainard, TA; Carballo, LH; Epperly, AH; Fisher, JC; Goetz, AS; Hommel, JD; Ignar, DM; Larkin, AL; Noble, KN; Shearer, TW; Sorensen, SD; Speake, JD; Stroup, AE | 1 |
| Cander, S; Ersoy, C; Ertürk, E; Gül, CB; Imamoğlu, S; Kırhan, E; Kıyıcı, S; Öz, Ö; Sarandol, E; Sığırlı, D; Tuncel, E; Ünal, OK; Yorulmaz, H | 1 |
| Böhm, M; Kazakov, A; Laufs, U; Lenski, M; Marx, N | 1 |
| Atilgan, D; Boztepe, O; Erdemir, F; Markoc, F; Sahin, S; Suha-Parlaktas, B | 1 |
| Cho, JH; Ham, DS; Kim, ES; Kim, JW; Park, HS; Sun, C; Yeom, JA; Yoon, KH | 1 |
| Balooch, FD; Fatemi, SJ; Golbafan, MR; Iranmanesh, M; Saljooghi, AS | 1 |
| de Lemos, ET; Fernandes, R; Mascarenhas-Melo, F; Mega, C; Oliveira, J; Reis, F; Teixeira, F; Vala, H | 1 |
| Holst, JJ; Liu, MK; Salen, G; Saumoy, M; Shang, Q; Xu, G | 1 |
| Ahmad, Z; Chung, JH; Kadir, AA; Somchit, N; Yaacob, A; Zakaria, ZA | 1 |
| Rabasseda, X | 1 |
| Choi, SH; Hong, ES; Jang, HC; Kang, SM; Khang, AR; Lim, S; Park, KS; Shin, H; Walford, GA; Yoon, JW | 1 |
| Ahrén, B; Deacon, CF; Mannucci, E | 1 |
| Allister, EM; Bhattacharjee, A; Wheeler, MB | 1 |
| Cutillas, B; Hernández-Mir, G; Llorens, J; Saldaña-Ruíz, S; Sedó-Cabezón, L | 1 |
| Cheetham, S; Francis, J; Kirby, M; Poucher, SM; Vickers, SP; Zinker, B | 1 |
| Burgmaier, M; Esser, M; Liberman, A; Ludwig, A; Marx, N; Ostertag, R; Vasic, D; Vittone, F; Walcher, D | 1 |
| Aschner, P; Chan, J; Dain, MP; Echtay, A; Fonseca, V; Owens, DR; Picard, S; Pilorget, V; Wang, E | 1 |
| Gupta, R; Keshwani, P; Saxena, GN; Srivastava, S | 1 |
| Bailey, T; Davies, M; Filetti, S; Furber, S; Garber, AJ; Montanya, E; Nauck, MA; Pratley, RE; Thomsen, AB | 1 |
| Isogawa, A; Iwamoto, M; Koike, K; Ohki, T; Ohsugi, M; Omata, M; Tagawa, K; Toda, N; Yoshida, H | 1 |
| Aono, M; Fujita, Y; Harashima, SI; Inagaki, N; Koizumi, T; Murata, Y; Ogura, M; Seike, M; Tanaka, D; Wang, Y; Yamane, S | 1 |
| Crajoinas, RO; Fonseca-Alaniz, MH; Giannocco, G; Girardi, AC; Maciel, RM; Oliveira, KC; Salles, TA; Venturini, G | 1 |
| Badole, SL; Bagul, PP; Bodhankar, SL; Coutinho, EC; Ghule, AE; Joshi, AC; Khedkar, VM; Khose, RD; Mahamuni, SP; Raut, CG; Wagh, NK | 1 |
| Katz, DP; Sample, CH; Swithers, SE | 1 |
| Cress, AB; Duleba, AJ; Ortega, I; Sokalska, A; Stanley, SD; Stener-Victorin, E; Villanueva, JA; Wong, DH | 1 |
| Arjona Ferreira, JC; Barzilai, N; Goldstein, BJ; Golm, GT; Guo, H; Kaufman, KD; Marre, M; Sisk, CM | 1 |
| Kanamori, A; Kubota, A; Maeda, H; Matsuba, I; Tanaka, Y; Terauchi, Y | 1 |
| Danner, RL; Figg, WD; Henning, SA; Jarosinski, PF; Moriyama, B; Penzak, SR; Walsh, TJ; Wayne, AS | 1 |
| Abecia, LC; Casado, A; Casis, L; Echevarría, E; Macarulla, MT; Portillo, MP; Rodríguez, VM; Saracíbar, G | 1 |
| Cory-Slechta, DA; Reeves, R; Richfield, EK; Thiruchelvam, M | 2 |
| Huhtaniemi, I; Li, X; Mäkelä, S; Poutanen, M; Santti, R; Strauss, L; Streng, T | 1 |
| DuBois, DW; Frye, GD; Hsiao, SH; Miranda, RC | 1 |
| Cory-Slechta, DA; Reeves, R; Thiruchelvam, M | 1 |
| Adamson, P; Arguedas, AG; Arrieta, AC; Blumer, J; Driscoll, T; Karlsson, MO; Lutsar, I; Milligan, P; Saez-Llorens, X; Vora, AJ; Walsh, TJ; Wood, N | 1 |
| Aglianò, M; Carminati, P; Lorenzoni, P; Pacifici, L; Ruggiero, V; Sorrentino, V; Stasi, MA; Taurelli, R; Ursillo, A; Weber, E | 1 |
| Ben Ari, T; Ben Eliezer, M; Eshet, R; Gat-Yablonski, G; Maor, G; Phillip, M | 1 |
| Cuzick, J; Locker, GY; Sainsbury, JR | 1 |
| Balthazart, J; Cornil, CA; Holloway, KS; Taziaux, M | 1 |
| Dix, DJ; Goetz, AK; Lambert, GR; Nesnow, S; Sun, G; Thai, SF; Tully, DB; Wolf, DC | 1 |
| Arun, KH; Kaul, CL; Kumar, S; Sharma, SS | 1 |
| Hazelton, GA; Juberg, DR; Mudra, DR; Parkinson, A | 1 |
| Bhatnagar, AS; Evans, DB; Gasser, JA; Green, JR; Ingold, P; Rebmann, A; Shen, V | 1 |
| Bergman, A; Blum, R; Chen, L; Dilzer, S; Herman, GA; Hilliard, D; Lasseter, K; Liu, F; Meehan, AG; Snyder, K; Stevens, C; Tanaka, W; Tanen, M; Wagner, JA; Wang, AQ; Zeng, W | 1 |
| Best, DS; Blystone, CR; Dix, DJ; Goetz, AK; Murrell, RN; Narotsky, MG; Nichols, HP; Ren, H; Rockett, JC; Schmid, JE; Thillainadarajah, I; Thompson, KE; Wolf, DC | 1 |
| Best, DS; Blystone, CR; Dix, DJ; Goetz, AK; Narotsky, MG; Nichols, HP; Ren, H; Rockett, JC; Schmid, JE; Strader, LF; Thillainadarajah, I; Wolf, DC | 1 |
| Allen, JW; Delker, DA; George, MH; Hester, SD; Jones, C; Leavitt, S; Moore, T; Nelson, G; Nesnow, S; Roop, BC; Sun, G; Thai, SF; Ward, WO; Winkfield, E; Wolf, DC | 1 |
| Farag, AT; Ibrahim, HH | 1 |
| Kantesaria, B; Krishna, G; Martinho, M; Pedicone, L; Sansone-Parsons, A | 1 |
| Del Castillo, A; Díaz, S; Domínguez-Gil, A; García Vargas, M; Martín, I; Sánchez, C | 1 |
| Corradi, LS; Falleiros-Júnior, LR; Santos, FC; Taboga, SR; Vilamaior, PS | 1 |
| Cajander, S; Holmäng, A; Lönn, M; Lystig, T; Mannerås, L; Seleskovic, Z; Stener-Victorin, E | 1 |
| Reznikov, OH; Tarasenko, LV | 1 |
| de Castro, VL; Destefani, CR; Diniz, C; Poli, P | 1 |
| Foster, G; Gutierrez, MJ; LaBadie, RR; Liu, P; Sharma, A | 1 |
| Baumane, L; Dambrova, M; Kalvinsh, I; Liepinsh, E; Muceniece, R; Vilskersts, R; Wikberg, JE; Zvejniece, L | 1 |
| Chandrasekar, P; Krishna, G; Martinho, M; Patino, H; Ullmann, AJ | 1 |
| Desfrere, L; Gressens, P; Olivier, P; Schwendimann, L; Verney, C | 1 |
| Ahrén, B | 2 |
| Ema, M; Hirata-Koizumi, M; Hirose, A; Imai, T; Kamata, E; Ogata, H | 1 |
| Fetisovova, Z; Kajo, K; Kubatka, P; Nosalova, G; Sadlonova, V | 1 |
| Alba, M; Amatruda, JM; Chen, Y; Hussain, S; Kaufman, KD; Langdon, RB; Raz, I; Stein, PP; Wu, M | 1 |
| Davies, MJ; Engel, SS; Loeys, T; Scott, R | 1 |
| Crownover, P; Damle, B; Glue, P; LaBadie, R | 1 |
| Ema, M; Hirata-Koizumi, M; Hirose, A; Imai, T; Kamata, E; Matsuyama, T | 1 |
| Fregly, MJ; Scammell, JG | 1 |
| Bremer, C; Lang, H; Oldhafer, KJ; Pichlmayr, R; Schüttler, W; Spiegel, HU | 1 |
| Machera, K | 1 |
| Brecht, HM; Haberstroh, U; Mihatsch, MJ; Oberle, G; Stahl, RA; Thaiss, F | 1 |
| Feldman, D; Garland, WA; Kaufman, LS; Meschter, CL; Mico, BA; Mortillo, M; Riley, JA | 1 |
| Chmielewski, PA; Dudchenko, P; Holley, LA; Miller, JA; Sarter, M | 1 |
| Day, P; ElSourady, H; Hall, IH; Izydore, RA; Simlot, R; Wong, OT | 1 |
| Bouillon, R; De Coster, R; Ederveen, AG; Nijs, J; van Herck, E; Vanderschueren, D | 1 |
| Adén, U; Bona, E; Fredholm, BB; Gilland, E; Hagberg, H | 1 |
| Ashby, J; Lefevre, PA | 1 |
| Flanagan, AM; Lea, CK | 1 |
| Buyse, J; De Coster, R; Decuypere, E; Dewil, E; Mast, J; Veldhuis, JD | 1 |
| Huang, ML; Langenaecken, C; Piotrovsky, VK; Van Peer, A | 1 |
| Bowden, C; DeCoster, R; Eto, I; Grubbs, CJ; Juliana, MM; Kelloff, GJ; Lubet, RA; Steele, VE; You, M | 1 |
| Balthazart, J; Castagna, C; Panzica, GC; Russo, C; Tlemçani, O; Viglietti-Panzica, C | 1 |
| Branch, RA; Carcillo, JA; Gillespie, DG; Jones, GS; Kochanek, PM; Korzekwa, KR; Kost, CK; Parise, RA; Whalen, MJ | 1 |
| Vergieva, T | 1 |
| Boonen, S; Bouillon, R; de Coster, R; Ederveen, AG; Moermans, K; Van Herck, E; Vandenput, L; Vanderschueren, D; Verstuyf, A | 1 |
| Bikoff, J; Ginsberg, DL; Sussman, N | 1 |
| Dunkel, L; Saukkonen, T; Wickman, S | 1 |
| Bailey, L; Dunner, DL; Laird, LK; Seabolt, JL; Sussman, N; Zajecka, J | 1 |
| Gotoh, M; Griffin, C; Hruban, Z | 1 |
| Baron, RL; Baumel, I; Freudenthal, RI; Kerchner, GA; Persing, RL | 1 |
| Akutsu, S; Iibo, K; Ishikawa, H; Matsuzaki, M; Nakamura, K | 1 |
| Matsuzaki, M; Okuyama, D; Sekino, M; Tsuchida, M; Yoshida, A | 1 |
| Hirata, A; Matsuzaki, M; Nakamura, K; Sakai, T; Sekino, M | 1 |
| Calandra, JC; Keplinger, ML; Lyman, FL | 2 |
| Graziani, M; Nencini, P; Valeri, P | 1 |
| Byloos, M; De Coster, R; Goeminne, N; Van Ginckel, R; Vanherck, W; Wouters, W | 1 |
| Prasad, RS; Vijayan, E | 1 |
| Crook, D; Devenport, MH; Lees, LJ; Wynn, V | 1 |
| Hrabálek, A; Nedvídková, J; Stolba, P; Vanzura, J; Vinsová, J | 1 |
| Matsushima, R; Sumi, C; Yokoro, K | 1 |
| Fregly, MJ | 1 |
| Rechcigl, M | 2 |
| Tjälve, H | 1 |
| Matsushima, T; Weisburger, JH | 1 |
| Gaines, TB; Kimbrough, RD; Linder, RE | 1 |
| Carter, EA; Isselbacher, KJ | 1 |
| Kroes, R; Verschuuren, HG | 1 |
| Doniach, I; Swettenham, KV | 1 |
| Laqueur, GL; Rechcigl, M | 1 |
| Anton, AH; Fregly, MJ | 1 |
16 review(s) available for triazoles and Body Weight
| Article | Year |
|---|---|
Combination therapy with DPP-4 inhibitors and insulin in patients with type 2 diabetes mellitus: what is the evidence?
Topics: Adamantane; Body Weight; Diabetes Complications; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Disease Progression; Drug Therapy, Combination; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Linagliptin; Nitriles; Piperidines; Purines; Pyrazines; Pyrrolidines; Quinazolines; Renal Insufficiency, Chronic; Sitagliptin Phosphate; Triazoles; Uracil; Vildagliptin | 2013 |
Cardiovascular effects of dipeptidyl peptidase-4 inhibitors: from risk factors to clinical outcomes.
Topics: Adamantane; Blood Glucose; Blood Pressure; Body Weight; Cardiovascular System; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Lipids; Nitriles; Pyrazines; Pyrrolidines; Risk Factors; Sitagliptin Phosphate; Triazoles; Vildagliptin | 2013 |
Comparative effects of sitagliptin and metformin in patients with type 2 diabetes mellitus: a meta-analysis.
Topics: Body Mass Index; Body Weight; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Resistance; Insulin-Secreting Cells; Metformin; Pyrazines; Sitagliptin Phosphate; Triazoles | 2013 |
[Oral add-on therapy to metformin in type 2 diabetes mellitus: a direct comparison between canagliflozin and sitagliptin].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; Body Weight; Canagliflozin; Clinical Trials, Phase III as Topic; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endpoint Determination; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Pyrazines; Randomized Controlled Trials as Topic; Sitagliptin Phosphate; Thiophenes; Triazoles; Young Adult | 2014 |
Comparison of GLP-1 analogues versus sitagliptin in the management of type 2 diabetes: systematic review and meta-analysis of head-to-head studies.
Topics: Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Fasting; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Lipids; Pyrazines; Randomized Controlled Trials as Topic; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2014 |
Mono-ovulation in women with polycystic ovary syndrome: a clinical review on ovulation induction.
Topics: Adult; Anovulation; Body Weight; Clomiphene; Female; Fertility Agents, Female; Gonadotropins; Humans; Infertility, Female; Letrozole; Life Style; Metformin; Nitriles; Overweight; Ovulation; Ovulation Induction; Patient Safety; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Reproductive Techniques, Assisted; Retrospective Studies; Triazoles | 2016 |
Incretin mimetics and dipeptidyl peptidase-4 inhibitors: innovative treatment therapies for type 2 diabetes.
Topics: Adamantane; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Fasting; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incretins; Nitriles; Peptides; Postprandial Period; Pyrazines; Pyrrolidines; Sitagliptin Phosphate; Triazoles; Venoms; Vildagliptin | 2008 |
Combination therapy with DPP-4 inhibitors and pioglitazone in type 2 diabetes: theoretical consideration and therapeutic potential.
Topics: Adamantane; Blood Glucose; Body Weight; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Edema; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lipids; Nitriles; Pioglitazone; Pyrazines; Pyrrolidines; Sitagliptin Phosphate; Thiazolidinediones; Treatment Outcome; Triazoles; Vildagliptin | 2008 |
[New blood glucose-lowering drugs in type 2 diabetes: a review of the literature].
Topics: Adamantane; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Liraglutide; Nitriles; Peptides; Pyrazines; Pyrrolidines; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Venoms; Vildagliptin | 2010 |
Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.
Topics: Adamantane; Body Weight; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Nitriles; Peptides; Pyrazines; Pyrrolidines; Quality of Life; Randomized Controlled Trials as Topic; Sitagliptin Phosphate; State Medicine; Thiazolidinediones; Triazoles; United Kingdom; Venoms; Vildagliptin | 2010 |
Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.
Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Fasting; Female; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Liraglutide; Male; Peptides; Pyrazines; Receptors, Glucagon; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Venoms | 2012 |
DPP-4 inhibitors.
Topics: Adamantane; Animals; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Lipid Metabolism; Metformin; Nitriles; Pioglitazone; Protease Inhibitors; Pyrazines; Pyrrolidines; Sitagliptin Phosphate; Substrate Specificity; Thiazolidinediones; Triazoles; Vildagliptin | 2007 |
GLP-1-based therapy of type 2 diabetes: GLP-1 mimetics and DPP-IV inhibitors.
Topics: Adamantane; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Enzyme Inhibitors; Exenatide; Gastric Emptying; Glucagon-Like Peptide 1; Hypoglycemic Agents; Incretins; Islets of Langerhans; Liraglutide; Nitriles; Peptides; Pyrazines; Pyrrolidines; Sitagliptin Phosphate; Triazoles; Venoms; Vildagliptin | 2007 |
Incretin mimetics and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetes.
Topics: Adamantane; Body Weight; Clinical Trials, Phase III as Topic; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Therapy, Combination; Exenatide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Insulin; Insulin Secretion; Nausea; Nitriles; Peptides; Pyrazines; Pyrrolidines; Randomized Controlled Trials as Topic; Receptors, Glucagon; Sitagliptin Phosphate; Triazoles; Venoms; Vildagliptin; Vomiting | 2008 |
Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Body Weight; Controlled Clinical Trials as Topic; Depressive Disorder; Female; Humans; Imipramine; Male; Piperazines; Selective Serotonin Reuptake Inhibitors; Sex Factors; Treatment Outcome; Triazoles; Weight Gain | 2001 |
Six-year perspectives on the safety and tolerability of nefazodone.
Topics: Age Factors; Antidepressive Agents, Second-Generation; Body Weight; Chronic Disease; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Obesity; Piperazines; Priapism; Seizures; Sexual Dysfunctions, Psychological; Suicide; Triazoles | 2002 |
34 trial(s) available for triazoles and Body Weight
| Article | Year |
|---|---|
[Comparative clinical study of pharmacokinetics and bioequivalence of Relonova and Maxalt].
Topics: Adult; Body Weight; Female; Humans; Male; Therapeutic Equivalency; Triazoles; Tryptamines; Young Adult | 2023 |
Sitagliptin as add-on therapy in insulin deficiency: biomarkers of therapeutic efficacy respond differently in type 1 and type 2 diabetes.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Body Weight; Cholesterol, LDL; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles | 2013 |
Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents.
Topics: Administration, Oral; Argentina; Blood Glucose; Body Weight; Canada; Diabetes Mellitus, Type 2; Drug Administration Schedule; Fasting; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; India; Insulin, Long-Acting; Male; Mexico; Middle Aged; Pyrazines; Sitagliptin Phosphate; South Africa; Treatment Outcome; Triazoles; Turkey; United States | 2013 |
Efficacy and tolerability of exenatide once weekly versus sitagliptin in patients with type 2 diabetes mellitus: a retrospective analysis of pooled clinical trial data.
Topics: Blood Glucose; Body Weight; Cardiovascular Diseases; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Double-Blind Method; Exenatide; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Peptides; Pyrazines; Retrospective Studies; Risk Factors; Sitagliptin Phosphate; Triazoles; Venoms | 2013 |
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial.
Topics: Adolescent; Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; Body Weight; Canagliflozin; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fasting; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Thiophenes; Treatment Outcome; Triazoles | 2013 |
Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study.
Topics: Blood Glucose; Blood Pressure; Body Weight; Canagliflozin; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diet; Double-Blind Method; Exercise; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Placebos; Pyrazines; Sitagliptin Phosphate; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Treatment Outcome; Triazoles; Triglycerides; Weight Loss | 2014 |
Dapagliflozin is effective as add-on therapy to sitagliptin with or without metformin: a 24-week, multicenter, randomized, double-blind, placebo-controlled study.
Topics: Benzhydryl Compounds; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Urinary Tract Infections; Weight Loss | 2014 |
The effects of dipeptidyl peptidase-4 inhibitors in treatment of obese patients with type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; Cholesterol, LDL; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Metformin; Middle Aged; Obesity; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Triglycerides | 2013 |
A pilot three-month sitagliptin treatment increases serum adiponectin level in Japanese patients with type 2 diabetes mellitus--a randomized controlled trial START-J study.
Topics: Adiponectin; Aged; Asian People; Biomarkers; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Pyrazines; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles | 2014 |
HARMONY 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metformin.
Topics: Aged; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Sulfonylurea Compounds; Treatment Outcome; Triazoles | 2014 |
The impact of weight loss on weight-related quality of life and health satisfaction: results from a trial comparing canagliflozin with sitagliptin in triple therapy among people with type 2 diabetes.
Topics: Adult; Age Factors; Aged; Body Weight; Canagliflozin; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glucosides; Glycated Hemoglobin; Health Behavior; Humans; Hypoglycemic Agents; Male; Middle Aged; Personal Satisfaction; Pyrazines; Quality of Life; Self Efficacy; Sex Factors; Sexual Behavior; Sitagliptin Phosphate; Thiophenes; Triazoles; Weight Loss | 2014 |
Efficacy of adding once-daily insulin glulisine in Japanese type 2 diabetes patients treated with insulin glargine and sitagliptin.
Topics: Adult; Asian People; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Japan; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles | 2014 |
Diabetes-related quality measure attainment: canagliflozin versus sitagliptin based on a pooled analysis of 2 clinical trials.
Topics: Blood Pressure; Body Mass Index; Body Weight; Canagliflozin; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipoproteins, LDL; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Thiophenes; Treatment Outcome; Triazoles | 2014 |
Impact of Male and Female Weight, Smoking, and Intercourse Frequency on Live Birth in Women With Polycystic Ovary Syndrome.
Topics: Adolescent; Adult; Body Mass Index; Body Weight; Clomiphene; Coitus; Female; Fertility Agents, Female; Humans; Infant, Newborn; Infertility, Male; Letrozole; Live Birth; Male; Nitriles; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Complications; Smoking; Triazoles; Young Adult | 2015 |
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
Topics: Adiponectin; Blood Glucose; Body Weight; C-Reactive Protein; Diabetes Mellitus, Type 2; Diet; Double-Blind Method; Drug Therapy, Combination; Exercise; Female; Humans; Hypoglycemic Agents; Inflammation; Insulin Resistance; Insulin-Secreting Cells; Male; Metformin; Middle Aged; Pioglitazone; Pyrazines; Resistin; Sitagliptin Phosphate; Thiazolidinediones; Triazoles; Tumor Necrosis Factor-alpha | 2010 |
Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatment.
Topics: Adult; Body Weight; Diabetes Mellitus, Type 2; Exenatide; Female; Health Status; Humans; Hypoglycemic Agents; Male; Mental Health; Middle Aged; Patient Satisfaction; Peptides; Pioglitazone; Pyrazines; Quality of Life; Sitagliptin Phosphate; Thiazolidinediones; Treatment Outcome; Triazoles; Venoms | 2011 |
Population pharmacokinetic analysis of letrozole in Japanese postmenopausal women.
Topics: Aged; Antineoplastic Agents; Aromatase Inhibitors; Aryl Hydrocarbon Hydroxylases; Asian People; Bilirubin; Body Weight; Creatinine; Cytochrome P-450 CYP2A6; Estradiol; Estrone; Female; Genotype; Humans; Letrozole; Nitriles; Polymorphism, Genetic; Postmenopause; Triazoles | 2011 |
Effect of sitagliptin monotherapy on serum total ghrelin levels in people with type 2 diabetes.
Topics: Aged; Analysis of Variance; Biomarkers; Blood Glucose; Body Mass Index; Body Weight; Chi-Square Distribution; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Down-Regulation; Female; Ghrelin; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles; Turkey | 2011 |
Comparison between sitagliptin as add-on therapy to insulin and insulin dose-increase therapy in uncontrolled Korean type 2 diabetes: CSI study.
Topics: Adult; Aged; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fasting; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Triazoles; Waist Circumference | 2012 |
Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial.
Topics: Adult; Aged; Body Weight; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Glargine; Insulin, Long-Acting; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2012 |
Comparing the efficacy and safety profile of sitagliptin versus glimepiride in patients of type 2 diabetes mellitus inadequately controlled with metformin alone.
Topics: Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Male; Metformin; Pyrazines; Sitagliptin Phosphate; Sulfonylurea Compounds; Time Factors; Treatment Outcome; Triazoles | 2012 |
Efficacy and safety of switching from the DPP-4 inhibitor sitagliptin to the human GLP-1 analog liraglutide after 52 weeks in metformin-treated patients with type 2 diabetes: a randomized, open-label trial.
Topics: Adult; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Liraglutide; Metformin; Nausea; Patient Satisfaction; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2012 |
Efficacy and safety of switching from basal insulin to sitagliptin in Japanese type 2 diabetes patients.
Topics: Aged; Asian People; Body Mass Index; Body Weight; C-Peptide; Demography; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Japan; Male; Pyrazines; ROC Curve; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2013 |
Efficacy and safety of sitagliptin versus glipizide in patients with type 2 diabetes and moderate-to-severe chronic renal insufficiency.
Topics: Body Weight; Diabetes Mellitus, Type 2; Female; Glipizide; Humans; Hypoglycemic Agents; Male; Pyrazines; Renal Insufficiency, Chronic; Sitagliptin Phosphate; Triazoles | 2013 |
Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration.
Topics: Aging; Alleles; Antifungal Agents; Body Weight; Child; Child, Preschool; Cohort Studies; Female; Genotype; Humans; Immunocompromised Host; Injections, Intravenous; Liver Function Tests; Male; Models, Biological; Pyrimidines; Triazoles; Voriconazole | 2004 |
Breast surgery in the 'Arimidex, Tamoxifen Alone or in Combination' (ATAC) trial: American women are more likely than women from the United Kingdom to undergo mastectomy.
Topics: Age Factors; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Breast Neoplasms; Chemotherapy, Adjuvant; Decision Making; Female; Humans; Mastectomy; Middle Aged; Neoplasm Staging; Nitriles; Odds Ratio; Postmenopause; Risk Factors; Tamoxifen; Triazoles; United Kingdom; United States | 2004 |
Pharmacokinetics and pharmacodynamic effects of the oral DPP-4 inhibitor sitagliptin in middle-aged obese subjects.
Topics: Adenosine Deaminase; Adenosine Deaminase Inhibitors; Administration, Oral; Blood Glucose; Body Weight; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; Glucagon-Like Peptide 1; Glucose Tolerance Test; Glycoproteins; Humans; Hypoglycemic Agents; Male; Middle Aged; Obesity; Pyrazines; Sitagliptin Phosphate; Triazoles | 2006 |
Posaconazole plasma concentrations in juvenile patients with invasive fungal infection.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Body Surface Area; Body Weight; Child; Female; Humans; Male; Mycoses; Treatment Outcome; Triazoles | 2007 |
Pharmacokinetic interaction between voriconazole and efavirenz at steady state in healthy male subjects.
Topics: Adolescent; Adult; Age Factors; Alkynes; Antifungal Agents; Area Under Curve; Benzoxazines; Body Weight; Capsules; Creatine Kinase; Cyclopropanes; Drug Interactions; Heart Block; Humans; Male; Metabolic Clearance Rate; Middle Aged; Pyrimidines; Reverse Transcriptase Inhibitors; Rhabdomyolysis; Tablets; Triazoles; Voriconazole | 2008 |
Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Antifungal Agents; Body Weight; Chronic Disease; Diarrhea; Double-Blind Method; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Opportunistic Infections; Racial Groups; Sex Factors; Transplantation, Homologous; Triazoles | 2007 |
Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes.
Topics: Adult; Aged; Area Under Curve; Body Weight; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2008 |
Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes.
Topics: Analysis of Variance; Biomarkers; Blood Glucose; Body Weight; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lipids; Male; Metformin; Middle Aged; Pyrazines; Rosiglitazone; Sitagliptin Phosphate; Thiazolidinediones; Treatment Outcome; Triazoles; Triglycerides | 2008 |
The role of sex steroids in the regulation of insulin sensitivity and serum lipid concentrations during male puberty: a prospective study with a P450-aromatase inhibitor.
Topics: Adolescent; Aromatase Inhibitors; Body Composition; Body Height; Body Weight; Double-Blind Method; Enzyme Inhibitors; Estradiol; Gonadal Steroid Hormones; Humans; Insulin; Insulin Resistance; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Letrozole; Lipids; Male; Nitriles; Prospective Studies; Puberty; Puberty, Delayed; Testosterone; Triazoles | 2002 |
Metabolic effects of low-dose fluconazole in healthy female users and non-users of oral contraceptives.
Topics: Adult; Antifungal Agents; Apolipoproteins; Body Weight; Contraceptives, Oral, Hormonal; Female; Fluconazole; Glucose Tolerance Test; Gonadal Steroid Hormones; Hormones; Humans; Hydrocortisone; Lipids; Lipoproteins; Sex Hormone-Binding Globulin; Triazoles | 1989 |
163 other study(ies) available for triazoles and Body Weight
| Article | Year |
|---|---|
Adenosine Receptors Modulate the Exogenous Ketogenic Supplement-Evoked Alleviating Effect on Lipopolysaccharide-Generated Increase in Absence Epileptic Activity in WAG/Rij Rats.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Body Weight; Dietary Supplements; Disease Models, Animal; Epilepsy, Absence; Injections, Intraperitoneal; Ketones; Ketosis; Lipopolysaccharides; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Wistar; Receptors, Purinergic P1; Triazoles; Xanthines | 2021 |
1,2,3-Triazolyl ester of ketorolac (15K), a potent PAK1 blocker, inhibits both growth and metastasis of orthotopic human pancreatic cancer xenografts in mice.
Topics: Animals; Body Weight; Cell Line, Tumor; Cell Proliferation; Esters; Hemodynamics; Humans; Inhibitory Concentration 50; Ketorolac; Mice; Mice, Nude; Neoplasm Invasiveness; Triazoles; Xenograft Model Antitumor Assays | 2019 |
Tankyrase inhibition ameliorates lipid disorder via suppression of PGC-1α PARylation in db/db mice.
Topics: Abdominal Fat; Adipose Tissue, White; Animals; Body Weight; Diabetes Mellitus, Type 2; Dyslipidemias; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Obesity; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Poly ADP Ribosylation; Sulfones; Tankyrases; Triazoles | 2020 |
3-Amino-1,2,4-Triazole Induces Quick and Strong Fat Loss in Mice with High Fat-Induced Metabolic Syndrome.
Topics: Animals; Body Weight; Disease Models, Animal; Male; Metabolic Syndrome; Mice; Triazoles | 2020 |
Initial posaconazole dosing to achieve therapeutic serum posaconazole concentrations among children, adolescents, and young adults receiving delayed-release tablet and intravenous posaconazole.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Body Weight; Child; Child, Preschool; Delayed-Action Preparations; Female; Hematologic Diseases; Humans; Immunocompromised Host; Infusions, Intravenous; Invasive Fungal Infections; Male; Neoplasms; Retrospective Studies; Tablets; Treatment Outcome; Triazoles; Young Adult | 2020 |
Short-term toxicity study of 1-aminobenzotraizole, a CYP inhibitor, in Wistar rats.
Topics: Animals; Body Weight; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Female; Male; Organ Size; Rats; Rats, Wistar; Toxicity Tests; Triazoles | 2022 |
Exercise differentially affects metabolic functions and white adipose tissue in female letrozole- and dihydrotestosterone-induced mouse models of polycystic ovary syndrome.
Topics: Adipocytes; Adipogenesis; Adipose Tissue, White; Animals; Body Composition; Body Weight; Cell Size; Dihydrotestosterone; Disease Models, Animal; Feeding Behavior; Female; Gene Expression Regulation; Glucose Tolerance Test; Insulin Resistance; Letrozole; Lipid Metabolism; Liver; Mice, Inbred C57BL; Nitriles; Organ Size; Phenotype; Physical Conditioning, Animal; Polycystic Ovary Syndrome; Signal Transduction; Triazoles; Triglycerides | 2017 |
Protective effects of GABA against metabolic and reproductive disturbances in letrozole induced polycystic ovarian syndrome in rats.
Topics: Androgen Antagonists; Animals; Blood Glucose; Body Weight; Catalase; Estradiol; Female; gamma-Aminobutyric Acid; Insulin Resistance; Letrozole; Nitriles; Ovary; Peroxidase; Polycystic Ovary Syndrome; Protective Agents; Rats; Reproduction; Superoxide Dismutase; Testosterone; Triazoles | 2017 |
Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia.
Topics: Animals; Autophagy; Biomarkers; Body Weight; Cachexia; Cisplatin; Disease Models, Animal; Forkhead Box Protein O3; Growth Hormone; Indoles; Male; Mitochondria; Mitochondrial Dynamics; Muscle, Skeletal; Oligopeptides; Organ Size; Organelle Biogenesis; Oxidative Stress; Phosphorylation; Piperidines; Proto-Oncogene Proteins c-akt; Rats; Secretagogues; Triazoles | 2017 |
Oxidative stress burden inhibits spermatogenesis in adult male rats: testosterone protective effect.
Topics: Aging; Animals; Biomarkers; Body Weight; Estradiol; Follicle Stimulating Hormone; Grape Seed Extract; Inflammation; Letrozole; Male; Methotrexate; Nitriles; Organ Size; Oxidative Stress; Protective Agents; Rats, Sprague-Dawley; Seminiferous Tubules; Sperm Count; Sperm Motility; Spermatogenesis; Testosterone; Triazoles | 2018 |
Antiandrogen Treatment Ameliorates Reproductive and Metabolic Phenotypes in the Letrozole-Induced Mouse Model of PCOS.
Topics: Adipocytes; Androgen Antagonists; Animals; Aromatase Inhibitors; Body Weight; Disease Models, Animal; Estrous Cycle; Female; Flutamide; Follicle Stimulating Hormone; Letrozole; Luteinizing Hormone; Mice; Nitriles; Ovary; Phenotype; Pituitary Gland; Polycystic Ovary Syndrome; Receptors, LHRH; Reproduction; Steroid 17-alpha-Hydroxylase; Testosterone; Triazoles | 2018 |
Rufinamide, an antiepileptic drug, improves cognition and increases neurogenesis in the aged gerbil hippocampal dentate gyrus via increasing expressions of IGF-1, IGF-1R and p-CREB.
Topics: Aging; Animals; Anticonvulsants; Body Weight; Brain-Derived Neurotrophic Factor; Cognition; CREB-Binding Protein; Dentate Gyrus; Gene Expression Regulation; Gerbillinae; Insulin-Like Growth Factor I; Ki-67 Antigen; Male; Microscopy, Fluorescence; Neurogenesis; Receptor, IGF Type 1; Receptor, trkB; Triazoles | 2018 |
Penconazole alters redox status, cholinergic function and lung's histoarchitecture of adult rats: Reversal effect of vitamin E.
Topics: Acetylcholinesterase; Animals; Antioxidants; Body Weight; Cholinergic Agents; Hydrogen Peroxide; Lipid Peroxidation; Lung; Lung Injury; Male; Malondialdehyde; Organ Size; Oxidation-Reduction; Rats, Wistar; Triazoles; Vitamin E | 2018 |
Therapeutic potentials of Quercetin in management of polycystic ovarian syndrome using Letrozole induced rat model: a histological and a biochemical study.
Topics: Animals; Antioxidants; Biomarkers; Biopsy; Body Weight; Disease Management; Disease Models, Animal; Estrous Cycle; Female; Humans; Letrozole; Lipid Metabolism; Lipids; Nitriles; Ovarian Follicle; Ovary; Polycystic Ovary Syndrome; Quercetin; Rats; Triazoles | 2018 |
Long chain fatty acid coenzyme A ligase (FACL) regulates triazophos-induced stimulation of reproduction in the small brown planthopper (SBPH), Laodelphax striatellus (Fallen).
Topics: Animals; Body Weight; Coenzyme A Ligases; Down-Regulation; Female; Gene Expression; Gene Silencing; Glycerol; Hemiptera; Insecticides; Organothiophosphates; Oryza; Plant Diseases; Proteomics; Real-Time Polymerase Chain Reaction; Reproduction; Triazoles; Up-Regulation; Zea mays | 2018 |
Ghrelin Receptor Antagonism of Methamphetamine-Induced Conditioned Place Preference and Intravenous Self-Administration in Rats.
Topics: Administration, Intravenous; Analysis of Variance; Animals; Body Weight; Central Nervous System Stimulants; Conditioning, Psychological; Glycine; Male; Methamphetamine; Rats, Wistar; Receptors, Ghrelin; Self Administration; Spatial Behavior; Time Factors; Triazoles | 2018 |
Inhibition of prolyl hydroxylase domain (PHD) by JTZ-951 reduces obesity-related diseases in the liver, white adipose tissue, and kidney in mice with a high-fat diet.
Topics: Adipose Tissue, White; Animals; Body Weight; Diet, High-Fat; Fatty Liver; Kidney; Liver; Male; Mice; Mice, Inbred C57BL; N-substituted Glycines; Obesity; Prolyl Hydroxylases; Pyridines; Triazoles | 2019 |
Population pharmacokinetics of cyclosporine in Chinese children receiving hematopoietic stem cell transplantation.
Topics: Adolescent; Antifungal Agents; Asian People; Body Weight; Child; Child, Preschool; Cyclosporine; Cytochrome P-450 CYP3A; Drug Monitoring; Female; Glomerular Filtration Rate; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Models, Biological; Polymorphism, Genetic; Transplantation, Homologous; Triazoles | 2019 |
Oral L-glutamine increases active GLP-1 (7-36) amide secretion and improves glycemic control in stretpozotocin-nicotinamide induced diabetic rats.
Topics: Administration, Oral; Animals; Blood Glucose; Body Weight; Colon; Diabetes Mellitus, Experimental; Drinking; Gene Expression Regulation; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose Tolerance Test; Glutamine; Glycated Hemoglobin; Insulin; Lipid Metabolism; Male; Molecular Docking Simulation; Niacinamide; Oxidative Stress; Pancreas; Peptide Fragments; Protein Conformation; Pyrazines; Rats; Rats, Sprague-Dawley; Receptors, Glucagon; Sitagliptin Phosphate; Triazoles | 2013 |
Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats.
Topics: Adamantane; Animals; Blood Glucose; Blood Pressure; Body Weight; Cardiotonic Agents; Cholesterol; Diet, High-Fat; Dipeptidyl-Peptidase IV Inhibitors; Heart; Heart Rate; Insulin; Insulin Resistance; Male; Malondialdehyde; Membrane Potential, Mitochondrial; Mitochondria, Heart; Nitriles; Obesity; Oxidative Stress; Pyrazines; Pyrrolidines; Rats, Wistar; Reactive Oxygen Species; Sitagliptin Phosphate; Triazoles; Vildagliptin | 2013 |
Long-term treatment with Sitagliptin, a dipeptidyl peptidase-4 inhibitor, reduces colon carcinogenesis and reactive oxygen species in 1,2-dimethylhydrazine-induced rats.
Topics: 1,2-Dimethylhydrazine; Animals; Body Weight; Carcinogenesis; Colonic Neoplasms; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Intestinal Mucosa; Intestines; Male; Mucins; Pyrazines; Random Allocation; Rats; Rats, Inbred F344; Reactive Oxygen Species; Sitagliptin Phosphate; Triazoles | 2013 |
Chelation of chromium(VI) by combining deferasirox and deferiprone in rats.
Topics: Animals; Benzoates; Body Weight; Chelating Agents; Chelation Therapy; Chromium; Deferasirox; Deferiprone; Male; Molecular Structure; Pyridones; Rats; Rats, Wistar; Tissue Distribution; Triazoles | 2013 |
The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes.
Topics: Animals; Blood Glucose; Body Weight; Bone and Bones; Cell Differentiation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Histocytochemistry; Male; Mice; Osteoblasts; Polymerase Chain Reaction; RNA; Triazoles; X-Ray Microtomography | 2014 |
Effect of concomitant administration of L-glutamine and cycloart-23-ene-3β, 25-diol (B2) with sitagliptin in GLP-1 (7-36) amide secretion, biochemical and oxidative stress in streptozotocin - nicotinamide induced diabetic Sprague Dawley rats.
Topics: Animals; Biomarkers; Blood Glucose; Body Weight; Colon; Diabetes Mellitus, Experimental; Drinking Behavior; Feeding Behavior; Glucagon-Like Peptide 1; Glutamine; Glycated Hemoglobin; Insulin; Lipid Metabolism; Male; Niacinamide; Oxidative Stress; Pancreas; Pyrazines; Rats; Rats, Sprague-Dawley; Sitagliptin Phosphate; Staining and Labeling; Streptozocin; Triazoles; Triterpenes | 2013 |
Protective effects of sitagliptin on myocardial injury and cardiac function in an ischemia/reperfusion rat model.
Topics: Animals; Apoptosis; Body Weight; Cardiotonic Agents; Creatine Kinase, MB Form; Disease Models, Animal; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Glutathione Peroxidase; Heart; Heart Ventricles; L-Lactate Dehydrogenase; Male; Malondialdehyde; Myocytes, Cardiac; Organ Size; Pyrazines; Rats; Rats, Sprague-Dawley; Receptors, Glucagon; Reperfusion Injury; Sitagliptin Phosphate; Superoxide Dismutase; Triazoles | 2013 |
Combined repeated-dose and reproductive/developmental toxicity screening test of 3-amino-5-mercapto-1,2,4-triazole in rats.
Topics: Anemia; Animals; Body Weight; Dose-Response Relationship, Drug; Eating; Female; Hepatocytes; Hypertrophy; Kidney Tubules; Litter Size; Male; No-Observed-Adverse-Effect Level; Organ Size; Pituitary Gland; Pregnancy; Rats; Rats, Sprague-Dawley; Reproduction; Structure-Activity Relationship; Thyroid Gland; Toxicity Tests; Triazoles | 2013 |
11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors still improve metabolic phenotype in male 11β-HSD1 knockout mice suggesting off-target mechanisms.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adipose Tissue; Animals; Blood Glucose; Body Weight; Brain; Dietary Fats; Dose-Response Relationship, Drug; Energy Metabolism; Female; Gene Expression Regulation, Enzymologic; Genotype; Glucose; Hypoglycemic Agents; Insulin; Liver; Male; Mice; Mice, Knockout; Molecular Structure; Pyrazoles; Pyrimidines; RNA, Messenger; Triazoles | 2013 |
Assessment of a nonsteroidal aromatase inhibitor, letrozole, in juvenile rats.
Topics: Animals; Aromatase Inhibitors; Behavior, Animal; Body Weight; Bone Development; Dose-Response Relationship, Drug; Eating; Female; Letrozole; Male; Motor Activity; Nitriles; Rats; Rats, Sprague-Dawley; Reproduction; Spermatozoa; Triazoles | 2013 |
Effect of sitagliptin treatment on metabolism and cardiac function in genetic diabetic mice.
Topics: Adiponectin; Animals; Blood Glucose; Body Weight; Diabetes Mellitus; Diet, High-Fat; Disease Models, Animal; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Heart; Heart Function Tests; Hypoglycemic Agents; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Myocardium; Pyrazines; Sitagliptin Phosphate; Triazoles | 2014 |
Characterization of the exocrine pancreas in the male Zucker diabetic fatty rat model of type 2 diabetes mellitus following 3 months of treatment with sitagliptin.
Topics: Administration, Oral; Animals; Blood Glucose; Body Weight; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Hypoglycemic Agents; Keratins; Ki-67 Antigen; Male; Metformin; Pancreas, Exocrine; Pyrazines; Rats; Rats, Zucker; Sitagliptin Phosphate; Triazoles | 2014 |
Chronic effects of strobilurin fungicides on development, growth, and mortality of larval Great Plains toads (Bufo cognatus).
Topics: Acetates; Animals; Body Weight; Bufonidae; Carbamates; Dose-Response Relationship, Drug; Drug Combinations; Female; Fungicides, Industrial; Larva; Male; Metamorphosis, Biological; Methacrylates; Mortality; Pyrazoles; Pyrimidines; Strobilurins; Toxicity Tests, Chronic; Triazoles; Water Pollutants, Chemical | 2014 |
Prevention of obesity-induced renal injury in male mice by DPP4 inhibition.
Topics: Animals; Body Weight; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Insulin Resistance; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Obesity; Triazoles | 2014 |
Stereoselectivity in bioaccumulation and excretion of epoxiconazole by mealworm beetle (Tenebrio molitor) larvae.
Topics: Animals; Body Weight; Diet; Epoxy Compounds; Fungicides, Industrial; Larva; Stereoisomerism; Tandem Mass Spectrometry; Tenebrio; Triazoles | 2014 |
Triazole GHS-R1a antagonists JMV4208 and JMV3002 attenuate food intake, body weight, and adipose tissue mass in mice.
Topics: Adipose Tissue; Animals; Body Weight; Dose-Response Relationship, Drug; Eating; Mice; Mice, Inbred C57BL; Picolinic Acids; Receptors, Ghrelin; Triazoles | 2014 |
DPP IV inhibitor treatment attenuates bone loss and improves mechanical bone strength in male diabetic rats.
Topics: Animals; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Compressive Strength; Diabetes Mellitus, Experimental; Dipeptidyl-Peptidase IV Inhibitors; Drug Evaluation, Preclinical; Male; Pyrazines; Rats; Rats, Wistar; Sitagliptin Phosphate; Streptozocin; Stress, Mechanical; Triazoles | 2014 |
Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: data from the Italian AIFA Anti-diabetics Monitoring Registry.
Topics: Adamantane; Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Exenatide; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Italy; Male; Metformin; Middle Aged; Monitoring, Physiologic; Nitriles; Peptides; Pyrazines; Pyrrolidines; Registries; Sex Factors; Sitagliptin Phosphate; Triazoles; Venoms; Vildagliptin | 2014 |
Time-course of protection by the selective A2A receptor antagonist SCH58261 after transient focal cerebral ischemia.
Topics: Adenosine A2 Receptor Antagonists; Analysis of Variance; Animals; Blood Cells; Body Weight; Brain Injuries; Disease Models, Animal; Ischemic Attack, Transient; Male; Myelin-Associated Glycoprotein; Neurologic Examination; Pyrimidines; Rats; Rats, Wistar; Time Factors; Triazoles | 2015 |
JTP-103237, a novel monoacylglycerol acyltransferase inhibitor, modulates fat absorption and prevents diet-induced obesity.
Topics: Acyltransferases; Animals; Body Weight; Chlorocebus aethiops; COS Cells; Diet, High-Fat; Eating; Glucose Tolerance Test; Humans; Intestinal Absorption; Lipid Metabolism; Male; Mice; Obesity; Oxygen Consumption; Peptide YY; Piperazines; Rats; Triazoles | 2015 |
Serum posaconazole levels among haematological cancer patients taking extended release tablets is affected by body weight and diarrhoea: single centre retrospective analysis.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Biological Availability; Body Mass Index; Body Weight; Delayed-Action Preparations; Diarrhea; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Tablets; Triazoles; Young Adult | 2015 |
Central leptin resistance and hypothalamic inflammation are involved in letrozole-induced polycystic ovary syndrome rats.
Topics: Animals; Body Weight; Eating; Female; Hypothalamus; Inflammation; Leptin; Letrozole; Nitriles; Ovary; Polycystic Ovary Syndrome; Rats, Sprague-Dawley; Suppressor of Cytokine Signaling 3 Protein; Triazoles | 2016 |
Effects of Exercise Intervention on Preventing Letrozole-Exposed Rats From Polycystic Ovary Syndrome.
Topics: Animals; Aromatase Inhibitors; Body Weight; Disease Models, Animal; Female; Follicle Stimulating Hormone; Insulin; Leptin; Letrozole; Nitriles; Obesity; Physical Conditioning, Animal; Polycystic Ovary Syndrome; Progesterone; Rats; Testosterone; Triazoles | 2017 |
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia.
Topics: Animals; Animals, Newborn; Antineoplastic Agents; Body Weight; Cachexia; Calcium; CHO Cells; Cisplatin; Cricetinae; Cricetulus; Eating; Growth Hormone; Indoles; Male; Muscle, Skeletal; Piperidines; Rats; Rats, Wistar; Receptors, Ghrelin; Triazoles; Wasting Disease, Chronic | 2017 |
Prediction of Plasma Concentration-time Profiles of Drugs in Humans from Animals Following Oral Administration: An Allometric Approach.
Topics: Administration, Oral; Animals; Body Weight; Enoxacin; Fluoroquinolones; Half-Life; Humans; Linezolid; Metabolic Clearance Rate; Models, Biological; Monosaccharides; Sildenafil Citrate; Triazoles; Venlafaxine Hydrochloride | 2016 |
Epoxiconazole causes changes in testicular histology and sperm production in the Japanese quail (Coturnix coturnix japonica).
Topics: Animals; Body Weight; Coturnix; Dose-Response Relationship, Drug; Epoxy Compounds; Female; Fungicides, Industrial; Male; Organ Size; Spermatozoa; Testis; Triazoles | 2008 |
Effects of maternal exposure to an aromatase inhibitor on sexual behaviour and neurochemical and endocrine aspects of adult male rat.
Topics: Animals; Aromatase Inhibitors; Biogenic Monoamines; Body Weight; Brain Chemistry; Endocrine System; Female; Letrozole; Male; Maternal Exposure; Nitriles; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Sexual Behavior, Animal; Testosterone; Triazoles | 2008 |
Uterotrophic assay, Hershberger assay, and subacute oral toxicity study of 3-amino-1,2,4-triazole based on the Organization for Economic Co-operation and Development draft protocols.
Topics: Administration, Oral; Animals; Antithyroid Agents; Biological Assay; Body Weight; Dose-Response Relationship, Drug; Endocrine Disruptors; Female; Guidelines as Topic; Injections, Subcutaneous; Male; Orchiectomy; Organ Size; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Thyrotropin; Thyroxine; Time Factors; Toxicity Tests, Acute; Triazoles; Triiodothyronine; Uracil; Uterus | 2009 |
Acute dipeptidyl peptidase-4 inhibition rapidly enhances insulin-mediated suppression of endogenous glucose production in mice.
Topics: Animals; Blood Glucose; Body Weight; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glucose Clamp Technique; Glucose Tolerance Test; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Mice; Mice, Inbred C57BL; Peptides; Pyrazines; Sitagliptin Phosphate; Triazoles; Venoms | 2009 |
Three conazoles increase hepatic microsomal retinoic acid metabolism and decrease mouse hepatic retinoic acid levels in vivo.
Topics: Animals; Blotting, Western; Body Weight; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Fungicides, Industrial; Gene Expression Profiling; Liver; Male; Mice; Microsomes, Liver; Nitriles; Organ Size; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spectrometry, Mass, Electrospray Ionization; Tretinoin; Triazoles | 2009 |
Side effects of anastrozole in the experimental pre-menopausal mammary carcinogenesis.
Topics: Anastrozole; Animals; Aromatase Inhibitors; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Nitriles; Rats; Rats, Sprague-Dawley; Triazoles; Uterus; Vagina | 2009 |
Collaborative work on evaluation of ovarian toxicity. 8) Two- or four-week repeated-dose studies and fertility study of Anastrozole in female rats.
Topics: Anastrozole; Animals; Aromatase Inhibitors; Body Weight; Corpus Luteum; Drug Administration Schedule; Estrous Cycle; Female; Fertility; Japan; Male; Nitriles; Organ Size; Ovarian Follicle; Ovary; Pregnancy; Public-Private Sector Partnerships; Rats; Rats, Inbred F344; Societies, Scientific; Specific Pathogen-Free Organisms; Toxicity Tests; Triazoles; Uterus | 2009 |
Role of 20-hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes.
Topics: Amidines; Angiotensin II; Animals; Blood Glucose; Body Weight; Carbachol; Cytochrome P-450 CYP4A; Diabetes Mellitus, Experimental; Endothelin-1; Enzyme Inhibitors; Histamine; Hydroxyeicosatetraenoic Acids; Kidney; Male; Mesenteric Arteries; Microsomes; Nitroprusside; Norepinephrine; Perfusion; Rats; Rats, Wistar; Renal Artery; Triazoles; Vasoconstriction; Vasodilation | 2009 |
Gender-related difference in the toxicity of 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)benzotriazole in rats: relationship to the plasma concentration, in vitro hepatic metabolism, and effects on hepatic metabolizing enzyme activity.
Topics: Administration, Oral; Animals; Body Weight; Chromatography, High Pressure Liquid; Female; In Vitro Techniques; Liver; Male; Microsomes, Liver; NADPH-Ferrihemoprotein Reductase; Rats; Rats, Sprague-Dawley; Ribosomal Protein S9; Ribosomal Proteins; Sex Factors; Tandem Mass Spectrometry; Toxicity Tests; Triazoles | 2009 |
Effect of mitratapide on body composition, body measurements and glucose tolerance in obese Beagles.
Topics: Absorptiometry, Photon; Adipose Tissue; Animals; Anti-Obesity Agents; Body Composition; Body Weight; Dog Diseases; Dogs; Eating; Female; Glucose Tolerance Test; Obesity; Piperazines; Triazoles | 2009 |
Clozapine and quetiapine acutely reduce glucagon-like peptide-1 production and increase glucagon release in obese rats: implications for glucose metabolism and food choice behaviour.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Body Composition; Body Weight; Clozapine; Dibenzothiazepines; Dietary Fats; Disease Models, Animal; Eating; Exenatide; Food Preferences; Gene Expression Regulation; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Hypoglycemic Agents; Insulin Resistance; Male; Obesity; Peptides; Pyrazines; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Sitagliptin Phosphate; Triazoles; Venoms | 2009 |
Short-term exposure to sublethal tebuconazole induces physiological impairment in male zebrafish (Danio rerio).
Topics: Animals; Biomarkers; Body Weight; Environmental Exposure; Enzymes; Fungicides, Industrial; Glucose; Lactates; Lethal Dose 50; Lipid Metabolism; Male; Recovery of Function; Time Factors; Toxicity Tests, Acute; Triazoles; Vitellogenins; Zebrafish | 2010 |
Uterine and fetal blood flow indexes and fetal growth assessment after chronic estrogen suppression in the second half of baboon pregnancy.
Topics: Animals; Aromatase Inhibitors; Blood Pressure; Body Weight; Estradiol; Estrogens; Female; Fetal Development; Fetus; Letrozole; Models, Animal; Nitriles; Papio anubis; Placental Circulation; Pregnancy; Pregnancy, Animal; Regional Blood Flow; Triazoles; Umbilical Arteries; Uterus | 2010 |
Treatment with sitagliptin or metformin does not increase body weight despite predicted reductions in urinary glucose excretion.
Topics: Body Weight; Diabetes Mellitus, Type 2; Glucose; Humans; Hypoglycemic Agents; Metformin; Models, Theoretical; Pyrazines; Sitagliptin Phosphate; Triazoles | 2009 |
The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA.
Topics: Animals; Blood Glucose; Blotting, Western; Body Weight; Culture Media; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dipeptidyl-Peptidase IV Inhibitors; Eicosanoids; Glucagon-Like Peptide 1; Hypertrophy, Left Ventricular; Hypoglycemic Agents; In Vitro Techniques; Mice; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Organ Size; Phospholipases A2; Pioglitazone; Prostaglandin-Endoperoxide Synthases; Protective Agents; Pyrazines; Sitagliptin Phosphate; Thiazolidinediones; Triazoles | 2010 |
Deferasirox decreases age-associated iron accumulation in the aging F344XBN rat heart and liver.
Topics: Aging; Animals; Apoptosis; Benzoates; Body Weight; Deferasirox; Heart; In Situ Nick-End Labeling; Iron; Iron Chelating Agents; Iron Overload; Liver; Male; Myocardium; Myocytes, Cardiac; Organ Size; Rats; Rats, Inbred F344; Trace Elements; Triazoles | 2010 |
Treatment of familial male-limited precocious puberty (testotoxicosis) with anastrozole and bicalutamide in a boy with a novel mutation in the luteinizing hormone receptor.
Topics: Anastrozole; Androgen Antagonists; Anilides; Aromatase Inhibitors; Body Height; Body Weight; Child Development; Child, Preschool; Drug Therapy, Combination; Humans; Male; Nitriles; Point Mutation; Puberty, Precocious; Receptors, LH; Tosyl Compounds; Triazoles | 2009 |
Sitagliptin augments angiotensin II-induced renal vasoconstriction in kidneys from rats with metabolic syndrome.
Topics: Angiotensin II; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Glycated Hemoglobin; Hypertension; Kidney; Male; Metabolic Syndrome; Proteinuria; Pyrazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Sitagliptin Phosphate; Triazoles; Vasoconstriction; Vasoconstrictor Agents | 2010 |
Differences in baseline characteristics between patients prescribed sitagliptin versus exenatide based on a US electronic medical record database.
Topics: Adult; Age Factors; Aged; Body Mass Index; Body Weight; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Exenatide; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insurance Claim Review; Lipids; Male; Middle Aged; Peptides; Pyrazines; Retrospective Studies; Sex Factors; Sitagliptin Phosphate; Socioeconomic Factors; Triazoles; Venoms | 2010 |
CYP26A1-specific antagonist influence on embryonic implantation, gene expression and endogenous retinoid concentration in rats.
Topics: Animals; Benzothiazoles; Body Weight; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Embryo Implantation; Female; Gene Expression; Liver; Organ Size; Pregnancy; Rats; Rats, Wistar; Retinoic Acid 4-Hydroxylase; Retinoids; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Uterus | 2010 |
Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat).
Topics: Animals; Blood Glucose; Blood Pressure; Body Weight; C-Reactive Protein; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Glycated Hemoglobin; Insulin; Insulin Resistance; Interleukin-1beta; Lipids; Male; Oxidative Stress; Pancreas; Pyrazines; Rats; Sitagliptin Phosphate; Triazoles | 2010 |
Removal of thallium by deferasirox in rats as biological model.
Topics: Animals; Benzoates; Body Weight; Chelating Agents; Chelation Therapy; Deferasirox; Disease Models, Animal; Dose-Response Relationship, Drug; Heavy Metal Poisoning; Iron; Male; Metals, Heavy; Poisoning; Random Allocation; Rats; Rats, Wistar; Spectrophotometry, Atomic; Thallium; Triazoles | 2011 |
Sitagliptin prevents the development of metabolic and hormonal disturbances, increased β-cell apoptosis and liver steatosis induced by a fructose-rich diet in normal rats.
Topics: Animals; Apoptosis; Blood Glucose; Body Weight; Diet; Dipeptidyl-Peptidase IV Inhibitors; Drinking; Drug Evaluation, Preclinical; Eating; Exenatide; Fatty Liver; Fructose; Glucose Tolerance Test; Hypoglycemic Agents; Insulin-Secreting Cells; Male; Metabolic Syndrome; Peptides; Pyrazines; Rats; Rats, Wistar; Sitagliptin Phosphate; Triazoles; Venoms | 2011 |
[New data from the US-American Diabetes Congress. GLP-1 effect: more than reducing blood glucose].
Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Liraglutide; Pyrazines; Randomized Controlled Trials as Topic; Sitagliptin Phosphate; Triazoles | 2010 |
Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice.
Topics: Adipocytes; Adipose Tissue; Adiposity; Animals; Anti-Inflammatory Agents; Body Weight; Cytokines; Dipeptidyl-Peptidase IV Inhibitors; Flow Cytometry; Glucose; Glucose Intolerance; Glucose Tolerance Test; Immunohistochemistry; Inflammation; Insulin; Islets of Langerhans; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Neutrophil Infiltration; Pyrazines; Reverse Transcriptase Polymerase Chain Reaction; Sitagliptin Phosphate; Triazoles | 2011 |
A novel approach for long-term oral drug administration in animal research.
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Protein Precursor; Anastrozole; Animal Experimentation; Animals; Antipsychotic Agents; Body Weight; Chromatography, Liquid; Disease Models, Animal; Female; Gels; Humans; Mass Spectrometry; Mice; Mice, Transgenic; Nitriles; Presenilin-1; Reproducibility of Results; tau Proteins; Triazoles | 2011 |
Effectiveness of sitagliptin in asian Indian patients with type 2 diabetes-an Indian tertiary diabetes care center experience.
Topics: Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Hypoglycemia; India; Insulin; Insulin Glargine; Insulin, Long-Acting; Male; Middle Aged; Pyrazines; Retrospective Studies; Sitagliptin Phosphate; Statistics, Nonparametric; Triazoles; Triglycerides | 2011 |
Propiconazole induces alterations in the hepatic metabolome of mice: relevance to propiconazole-induced hepatocarcinogenesis.
Topics: Animals; Body Weight; Chemical and Drug Induced Liver Injury; Fungicides, Industrial; Liver; Male; Metabolome; Mice; Mice, Inbred Strains; Molecular Structure; Organ Size; Triazoles | 2011 |
Growth arrest-specific protein 6 receptor antagonism impairs adipocyte differentiation and adipose tissue development in mice.
Topics: Adipocytes; Adipogenesis; Adipose Tissue; Animals; Benzocycloheptenes; Blood Glucose; Body Temperature; Body Weight; Cell Differentiation; Cell Size; Cells, Cultured; Embryonic Stem Cells; Intercellular Signaling Peptides and Proteins; Macrophages; Male; Mice; Mice, Inbred C57BL; Organ Size; Protein-Tyrosine Kinases; RNA, Messenger; Signal Transduction; Triazoles | 2011 |
Sitagliptin lowers glucagon and improves glucose tolerance in prediabetic obese SHROB rats.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Disease Models, Animal; Feeding Behavior; Glucagon; Glucagon-Like Peptide 1; Glyburide; Hypoglycemic Agents; Insulin; Insulin Secretion; Pyrazines; Rats; Sitagliptin Phosphate; Triazoles | 2011 |
Serum concentrations of rufinamide in children and adults with epilepsy: the influence of dose, age, and comedication.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Body Weight; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Intellectual Disability; Lennox Gastaut Syndrome; Male; Middle Aged; Seizures; Spasms, Infantile; Triazoles; Valproic Acid; Young Adult | 2011 |
Regulation of ingestive behaviors in the rat by GSK1521498, a novel micro-opioid receptor-selective inverse agonist.
Topics: Adiposity; Animals; Anti-Obesity Agents; Body Weight; Brain; Calibration; Conditioning, Operant; Data Interpretation, Statistical; Drinking Behavior; Feeding Behavior; Food Preferences; Guanosine 5'-O-(3-Thiotriphosphate); Indans; Injections, Intravenous; Male; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Satiety Response; Triazoles; Weight Loss | 2011 |
Effects of DPP-4 inhibition on cardiac metabolism and function in mice.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Body Weight; CD36 Antigens; Cell Membrane; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Fibrosis; Glucose Tolerance Test; Glucose Transporter Type 4; Glycation End Products, Advanced; Guanine; Heart; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Phosphorylation; Protein Transport; Pyrazines; Sitagliptin Phosphate; Triazoles; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2011 |
[The effect of diet induced obesity on testicular tissue and serum oxidative stress parameters].
Topics: Anastrozole; Animals; Aromatase Inhibitors; Biomarkers; Body Weight; Catalase; Diet, High-Fat; Glutathione; Gonadal Steroid Hormones; Infertility, Male; Lipid Peroxidation; Lipids; Male; Nitric Oxide; Nitriles; Obesity; Oxidative Stress; Pituitary Hormones, Anterior; Random Allocation; Rats; Rats, Wistar; Spermatogenesis; Superoxide Dismutase; Superoxide Dismutase-1; Testis; Triazoles | 2012 |
Both sitagliptin analogue & pioglitazone preserve the beta-cell proportion in the islets with different mechanism in non-obese and obese diabetic mice.
Topics: Animals; Apoptosis; Blood Glucose; Body Weight; Cell Proliferation; Diabetes Mellitus, Experimental; Fasting; Glucose Tolerance Test; Homeostasis; Insulin-Secreting Cells; Ki-67 Antigen; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Organ Size; Pioglitazone; Pyrazines; Sitagliptin Phosphate; Thiazolidinediones; Triazoles | 2011 |
Removal of cadmium by combining deferasirox and desferrioxamine chelators in rats.
Topics: Animals; Benzoates; Body Weight; Cadmium; Chelating Agents; Chelation Therapy; Deferasirox; Deferoxamine; Iron; Male; Rats; Rats, Wistar; Tissue Distribution; Triazoles | 2012 |
Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker diabetic fatty rat).
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Insulin; Kidney Glomerulus; Lipid Peroxidation; Lipids; Male; Obesity; Pyrazines; Rats; Rats, Zucker; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2011 |
The combination of colesevelam with sitagliptin enhances glycemic control in diabetic ZDF rat model.
Topics: Allylamine; Animals; Anticholesteremic Agents; Apoptosis; Bile Acids and Salts; Blood Glucose; Body Weight; Cell Proliferation; Cell Size; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Diet; Drug Synergism; Fluorescent Antibody Technique; Glucagon-Like Peptide 1; Glucose Tolerance Test; Hypoglycemic Agents; In Situ Nick-End Labeling; Insulin; Insulin-Secreting Cells; Ki-67 Antigen; Male; Postprandial Period; Pyrazines; Rats; Rats, Zucker; Receptors, G-Protein-Coupled; RNA, Messenger; Sitagliptin Phosphate; Triazoles | 2012 |
Lack of hepato- and nephrotoxicity induced by antifungal drug voriconazole in laboratory rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antifungal Agents; Aspartate Aminotransferases; Blood Urea Nitrogen; Body Weight; Creatinine; Dose-Response Relationship, Drug; gamma-Glutamyltransferase; Injections, Intraperitoneal; Kidney; Liver; Microscopy, Electron, Transmission; Molecular Structure; Organ Size; Pyrimidines; Rats; Rats, Sprague-Dawley; Toxicity Tests; Triazoles; Voriconazole | 2012 |
[Sitagliptin in the treatment of type 2 diabetes: new data presented during the American Diabetes Association annual meeting (San Diego, California, June 2011)].
Topics: Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Pyrazines; Sitagliptin Phosphate; Triazoles | 2011 |
MK-626, a dipeptidyl peptidase-4 inhibitor, does not improve the hyperglycemia or hyperinsulinemia of nonobese diabetic MKR mice.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dipeptidyl-Peptidase IV Inhibitors; Glucagon; Glucose; Glucose Intolerance; Homeostasis; Hyperglycemia; Hyperinsulinism; Incretins; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Obese; Phenylalanine; Triazoles | 2012 |
Vestibular toxicity of cis-2-pentenenitrile in the rat.
Topics: Animals; Behavior, Animal; Body Weight; Central Nervous System; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Activation; Epithelium; Fluoresceins; Fluorescent Dyes; Hair Cells, Auditory; Male; Microscopy, Electron, Scanning; Motor Activity; Nitriles; Rats; Rats, Long-Evans; Triazoles; Vestibular Diseases; Vestibule, Labyrinth | 2012 |
Effects of saxagliptin and sitagliptin on glycaemic control and pancreatic β-cell mass in a streptozotocin-induced mouse model of type 2 diabetes.
Topics: Adamantane; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Dipeptides; Drinking; Eating; Glucose Tolerance Test; Glycated Hemoglobin; Hypoglycemic Agents; Immunohistochemistry; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Pyrazines; Sitagliptin Phosphate; Triazoles | 2012 |
Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe (-/-) mice.
Topics: Animals; Apolipoproteins E; Arteriosclerosis; Body Weight; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Immunohistochemistry; Lipid Metabolism; Macrophages; Male; Mice; Mice, Inbred C57BL; Pyrazines; Sitagliptin Phosphate; Triazoles | 2012 |
The effectiveness of liraglutide in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus compared to sitagliptin and pioglitazone.
Topics: Adult; Alanine Transaminase; Blood Glucose; Body Weight; Comorbidity; Diabetes Mellitus, Type 2; Drug Evaluation; Drug Therapy, Combination; Fatty Liver; Female; Follow-Up Studies; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Inflammation; Liraglutide; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Multivariate Analysis; Non-alcoholic Fatty Liver Disease; Odds Ratio; Pioglitazone; Platelet Count; Pyrazines; Retrospective Studies; Sitagliptin Phosphate; Thiazolidinediones; Treatment Outcome; Triazoles | 2012 |
Dipeptidyl peptidase IV inhibition upregulates GLUT4 translocation and expression in heart and skeletal muscle of spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Body Weight; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Glucose; Glucose Transporter Type 4; Heart; Homeostasis; Intracellular Space; Male; Muscle, Skeletal; Myocytes, Cardiac; Phosphorylation; Protein Transport; Pyrazines; Rats; Rats, Inbred SHR; RNA, Messenger; Signal Transduction; Sitagliptin Phosphate; Triazoles; Up-Regulation | 2013 |
Cycloart-23-ene-3β, 25-diol stimulates GLP-1 (7-36) amide secretion in streptozotocin-nicotinamide induced diabetic Sprague Dawley rats: a mechanistic approach.
Topics: Animals; Biomarkers; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Drinking; Gene Expression Regulation; Glucagon-Like Peptide 1; Glucose Tolerance Test; Insulin; Male; Molecular Docking Simulation; Niacinamide; Oxidative Stress; Pancreas; Peptide Fragments; Protein Conformation; Pyrazines; Rats; Rats, Sprague-Dawley; Sitagliptin Phosphate; Time Factors; Triazoles; Triterpenes | 2013 |
Influence of ovarian and non-ovarian estrogens on weight gain in response to disruption of sweet taste--calorie relations in female rats.
Topics: Anastrozole; Animals; Aromatase Inhibitors; Body Weight; Energy Intake; Energy Metabolism; Female; Nitriles; Ovariectomy; Rats; Rats, Sprague-Dawley; Saccharin; Sweetening Agents; Taste; Triazoles; Weight Gain | 2013 |
Letrozole increases ovarian growth and Cyp17a1 gene expression in the rat ovary.
Topics: Animals; Aromatase Inhibitors; Bacterial Proteins; Body Weight; Cell Proliferation; Cells, Cultured; Coculture Techniques; Estrous Cycle; Female; Gene Expression; Granulosa Cells; Hormones; Letrozole; Nitriles; Organ Size; Ovary; Rats; Repressor Proteins; RNA, Messenger; Steroid 17-alpha-Hydroxylase; Theca Cells; Triazoles | 2013 |
Long-term efficacy and safety of sitagliptin in the treatment of Japanese Type 2 diabetes (ASSET-K1) to a target of HbA1c <7%.
Topics: Aged; Asian People; Blood Glucose; Body Mass Index; Body Weight; Diabetes Mellitus, Type 2; Fasting; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Postprandial Period; Pyrazines; Sitagliptin Phosphate; Triazoles | 2013 |
Pharmacokinetics of intravenous voriconazole in obese patients: implications of CYP2C19 homozygous poor metabolizer genotype.
Topics: Adolescent; Antifungal Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Body Weight; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Administration Schedule; Genotype; Humans; Injections, Intravenous; Male; Obesity; Pyrimidines; Triazoles; Voriconazole | 2013 |
Nefazodone alters NPY immunostaining in rat arcuate-paraventricular projection without changes in food intake and body weight.
Topics: Adipose Tissue; Adipose Tissue, Brown; Animals; Antidepressive Agents, Second-Generation; Arcuate Nucleus of Hypothalamus; Body Weight; Energy Intake; Immunohistochemistry; Male; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Piperazines; Rats; Rats, Sprague-Dawley; Triazoles | 2002 |
Behavioral sensitization and long-term neurochemical alterations associated with the fungicide triadimefon.
Topics: Animals; Autoradiography; Behavior, Animal; Body Weight; Brain Chemistry; Chromatography, High Pressure Liquid; Dopamine; Dopamine Plasma Membrane Transport Proteins; Electrochemistry; Fungicides, Industrial; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Motor Activity; Nerve Tissue Proteins; Neurotransmitter Agents; Nucleus Accumbens; Prefrontal Cortex; Receptors, Dopamine D1; Serotonin; Triazoles | 2003 |
Multiple structural and functional abnormalities in the p450 aromatase expressing transgenic male mice are ameliorated by a p450 aromatase inhibitor.
Topics: Adrenal Glands; Animals; Aromatase; Body Weight; Cryptorchidism; Disease Models, Animal; Endocrine System Diseases; Estradiol; Gynecomastia; Humans; Immunohistochemistry; Leydig Cells; Male; Mammary Glands, Human; Mice; Mice, Transgenic; Nitriles; Pituitary Gland; Promoter Regions, Genetic; Spermatogenesis; Testosterone; Triazoles; Ubiquitin C | 2004 |
Critically timed ethanol exposure reduces GABAAR function on septal neurons developing in vivo but not in vitro.
Topics: Analysis of Variance; Animals; Animals, Newborn; Anticonvulsants; Bicuculline; Body Weight; Cells, Cultured; Central Nervous System Depressants; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Embryo, Mammalian; Ethanol; Female; GABA Agonists; GABA Antagonists; GABA Modulators; gamma-Aminobutyric Acid; In Vitro Techniques; Male; Membrane Potentials; Neurons; Patch-Clamp Techniques; Penicillins; Picrotoxin; Pregnancy; Protein Synthesis Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Septum of Brain; Streptomycin; Time Factors; Triazoles; Up-Regulation; Zinc; Zolpidem | 2004 |
Expression of behavioral sensitization to the cocaine-like fungicide triadimefon is blocked by pretreatment with AMPA, NMDA and DA D1 receptor antagonists.
Topics: Animals; Behavior, Animal; Benzazepines; Body Weight; Brain Chemistry; Central Nervous System Stimulants; Cocaine; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fungicides, Industrial; Male; Mice; Mice, Inbred C57BL; Motor Activity; Piperazines; Receptors, AMPA; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Remoxipride; Serotonin; Triazoles | 2004 |
Ameliorating effects of the immunomodulator 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole in an experimental model of colitis in the rat.
Topics: Animals; Body Weight; Colitis; Colon; Cytokines; Diarrhea; Immunohistochemistry; Immunosuppressive Agents; Male; Neutrophil Infiltration; Organ Size; Peroxidase; Rats; Rats, Sprague-Dawley; Triazoles; Trinitrobenzenesulfonic Acid | 2004 |
The aromatase inhibitor letrozole increases epiphyseal growth plate height and tibial length in peripubertal male mice.
Topics: Animals; Aromatase; Aromatase Inhibitors; Body Weight; Collagen; Collagen Type II; Collagen Type X; Growth Plate; Immunohistochemistry; Letrozole; Male; Mice; Mice, Inbred ICR; Nitriles; Receptor, IGF Type 1; Sexual Maturation; Tail; Tibia; Triazoles | 2004 |
The effect of developmental exposure to the fungicide triadimefon on behavioral sensitization to triadimefon during adulthood.
Topics: Animals; Animals, Newborn; Autoradiography; Behavior, Animal; Body Weight; Brain Chemistry; Dose-Response Relationship, Drug; Female; Fungicides, Industrial; Male; Mice; Mice, Inbred C57BL; Motor Activity; Neuronal Plasticity; Neurotransmitter Agents; Triazoles | 2004 |
The effects of aromatase inhibition on testosterone-dependent conditioned rhythmic cloacal sphincter movements in male Japanese quail.
Topics: Animals; Aromatase Inhibitors; Body Weight; Cloaca; Conditioning, Operant; Coturnix; Defecation; Enzyme Inhibitors; Female; Male; Movement; Testosterone; Triazoles | 2004 |
Propiconazole-induced cytochrome P450 gene expression and enzymatic activities in rat and mouse liver.
Topics: Administration, Oral; Animals; Body Weight; Cytochrome P-450 Enzyme System; Fungicides, Industrial; Gene Expression; Liver; Male; Mice; Mice, Inbred Strains; Microsomes, Liver; Organ Size; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triazoles | 2005 |
Effects of adenosine and adenosine A2A receptor agonist on motor nerve conduction velocity and nerve blood flow in experimental diabetic neuropathy.
Topics: Adenosine; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Interactions; Neural Conduction; Phenethylamines; Purinergic P2 Receptor Agonists; Rats; Regional Blood Flow; Sciatic Nerve; Staining and Labeling; Streptozocin; Theophylline; Time Factors; Triazines; Triazoles | 2005 |
The effect of fenbuconazole on cell proliferation and enzyme induction in the liver of female CD1 mice.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Blotting, Western; Body Weight; Cell Enlargement; Cell Proliferation; Cytochrome P-450 CYP2B1; Cytochrome P450 Family 2; Cytochromes b5; Dose-Response Relationship, Drug; Enzyme Induction; Female; Fungicides, Industrial; Hepatocytes; Liver; Liver Neoplasms; Mice; Nitriles; Organ Size; Phenobarbital; Steroid Hydroxylases; Time Factors; Triazoles | 2006 |
A single intravenous administration of zoledronic acid prevents the bone loss and mechanical compromise induced by aromatase inhibition in rats.
Topics: Animals; Aromatase Inhibitors; Biomechanical Phenomena; Body Weight; Bone and Bones; Bone Density; Bone Density Conservation Agents; Diphosphonates; Estrogens; Female; Imidazoles; Injections, Intravenous; Letrozole; Nitriles; Organ Size; Osteocalcin; Osteoporosis; Ovariectomy; RANK Ligand; Rats; Rats, Wistar; Triazoles; Uterus; Zoledronic Acid | 2006 |
Effect of conazole fungicides on reproductive development in the female rat.
Topics: Administration, Oral; Animals; Animals, Newborn; Body Weight; Dose-Response Relationship, Drug; Estradiol; Estrus; Female; Fungicides, Industrial; Gestational Age; Litter Size; Liver; Male; Molecular Structure; Organ Size; Ovary; Pregnancy; Rats; Rats, Wistar; Reproduction; Sex Ratio; Triazoles; Vagina | 2006 |
Disruption of testosterone homeostasis as a mode of action for the reproductive toxicity of triazole fungicides in the male rat.
Topics: Anal Canal; Animals; Antifungal Agents; Body Weight; Cell Shape; Dose-Response Relationship, Drug; Eating; Female; Fertility; Fungicides, Industrial; Genitalia, Male; Homeostasis; Liver; Male; Nitriles; Organ Size; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Reproduction; Sexual Maturation; Sperm Motility; Spermatozoa; Testosterone; Time Factors; Triazoles | 2007 |
Toxicity profiles in mice treated with hepatotumorigenic and non-hepatotumorigenic triazole conazole fungicides: Propiconazole, triadimefon, and myclobutanil.
Topics: Animals; Body Weight; Carcinogenicity Tests; Carcinogens; Cell Proliferation; Cholesterol; Cytochrome P-450 Enzyme System; Diet; Female; Fungicides, Industrial; Lipids; Lipoproteins, HDL; Liver; Liver Neoplasms, Experimental; Male; Mice; Microsomes, Liver; Nitriles; Organ Size; Triazoles | 2006 |
Developmental toxic effects of antifungal flusilazole administered by gavage to mice.
Topics: Abnormalities, Drug-Induced; Animals; Antifungal Agents; Body Weight; Dose-Response Relationship, Drug; Female; Fetus; Male; Mice; Mice, Inbred ICR; Organ Size; Pregnancy; Silanes; Triazoles | 2007 |
Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Spain.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Body Weight; Caspofungin; Cost-Benefit Analysis; Echinocandins; Health Care Costs; Humans; Injections, Intravenous; Lipopeptides; Multivariate Analysis; Peptides, Cyclic; Pyrimidines; Severity of Illness Index; Spain; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Experimental endocrine therapies promote epithelial cytodifferentiation and ciliogenesis in the gerbil female prostate.
Topics: Animals; Body Weight; Cell Differentiation; Cilia; Epithelial Cells; Female; Gerbillinae; Gonadal Steroid Hormones; Hormone Replacement Therapy; Letrozole; Male; Nitriles; Organ Size; Prostate; Testosterone; Triazoles | 2007 |
A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome.
Topics: Adipocytes; Androgens; Animals; Aromatase Inhibitors; Body Composition; Body Weight; Dihydrotestosterone; Disease Models, Animal; Estrous Cycle; Female; Letrozole; Magnetic Resonance Imaging; Mesentery; Muscle, Skeletal; Nitriles; Organ Size; Ovary; Polycystic Ovary Syndrome; Rats; Rats, Wistar; Testosterone; Triazoles | 2007 |
[The role of the ovarian steroid aromatase in pathogenesis of reproductive cycles disorders].
Topics: Administration, Oral; Anestrus; Animals; Aromatase; Aromatase Inhibitors; Body Weight; Estrous Cycle; Female; Infertility, Female; Letrozole; Nitriles; Organ Size; Ovary; Rats; Rats, Wistar; Triazoles | 2007 |
Evaluation of neurodevelopmental effects on rats exposed prenatally to sulfentrazone.
Topics: Animals; Behavior, Animal; Body Weight; Comet Assay; Dose-Response Relationship, Drug; Ear; Eye; Female; Gestational Age; Herbicides; Leukocytes; Locomotion; Male; Maternal Behavior; Motor Skills; Muscle Strength; Mutagens; Nervous System; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Reflex; Sulfonamides; Testis; Time Factors; Triazoles | 2007 |
Functional evaluation of THIQ, a melanocortin 4 receptor agonist, in models of food intake and inflammation.
Topics: alpha-MSH; Animals; Anti-Inflammatory Agents; Body Weight; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Electron Spin Resonance Spectroscopy; Inflammation; Injections, Intraventricular; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Nitric Oxide; Peptides, Cyclic; Rats; Rats, Wistar; Receptor, Melanocortin, Type 4; Tetrahydroisoquinolines; Triazoles | 2007 |
Transient inhibition of astrocytogenesis in developing mouse brain following postnatal caffeine exposure.
Topics: Adenosine; Animals; Animals, Newborn; Apoptosis; Astrocytes; Behavior, Animal; Body Weight; Brain; Caffeine; Cell Differentiation; Cell Proliferation; Dose-Response Relationship, Drug; Glial Fibrillary Acidic Protein; Immunohistochemistry; Injections, Intraperitoneal; Mice; Microtubule-Associated Proteins; Models, Animal; Nerve Growth Factors; Organ Size; Phenethylamines; Pyrimidines; Receptor, Adenosine A2A; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Synaptophysin; Time Factors; Triazoles | 2007 |
A 52-week repeated dose toxicity study of ultraviolet absorber 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)benzotriazole in rats.
Topics: Administration, Oral; Alkaline Phosphatase; Animals; Blood Glucose; Body Weight; Dose-Response Relationship, Drug; Erythrocytes; Female; Heart; Liver; Male; No-Observed-Adverse-Effect Level; Organ Size; Radiation-Protective Agents; Rats; Rats, Sprague-Dawley; Sex Factors; Time Factors; Toxicity Tests, Chronic; Triazoles; Ultraviolet Rays | 2008 |
Preventive effects of letrozole in the model of premenopausal mammary carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Body Weight; Drug Screening Assays, Antitumor; Female; Letrozole; Mammary Neoplasms, Experimental; Menopause; Methylnitrosourea; Nitriles; Rats; Rats, Sprague-Dawley; Triazoles | 2008 |
Pharmacokinetic interactions of efavirenz and voriconazole in healthy volunteers.
Topics: Adult; Alkynes; Antifungal Agents; Benzoxazines; Body Weight; Cyclopropanes; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Epidemiologic Methods; Humans; Male; Pyrimidines; Reverse Transcriptase Inhibitors; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Lack of gender-related difference in the toxicity of 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)benzotriazole in preweaning rats.
Topics: Administration, Oral; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Blood Urea Nitrogen; Body Weight; Dose-Response Relationship, Drug; Female; L-Lactate Dehydrogenase; Liver; Male; Organ Size; Rats; Rats, Sprague-Dawley; Serum Albumin; Sex Factors; Triazoles | 2008 |
The effect of 3-amino-1,2,4-triazole on hepatic and renal deiodination of L-thyroxine to 3,5,3'-triiodothyronine.
Topics: Amitrole; Animals; Biotransformation; Body Weight; Kidney; Liver; Male; Organ Size; Rats; Rats, Inbred Strains; Thyroxine; Triazoles; Triiodothyronine | 1981 |
Beneficial effect of the platelet-activating factor antagonist WEB 2170 on reperfusion injury after orthotopic liver transplantation.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Azepines; Bilirubin; Body Weight; Graft Survival; Liver; Liver Function Tests; Liver Transplantation; Platelet Activating Factor; Platelet Aggregation Inhibitors; Reperfusion Injury; Swine; Time Factors; Triazoles | 1995 |
Developmental toxicity of cyproconazole, an inhibitor of fungal ergosterol biosynthesis, in the rat.
Topics: Abnormalities, Drug-Induced; Analysis of Variance; Animals; Antifungal Agents; Body Weight; Dose-Response Relationship, Drug; Embryo Loss; Embryonic and Fetal Development; Female; Male; Osteogenesis; Pregnancy; Random Allocation; Rats; Rats, Wistar; Teratogens; Triazoles | 1995 |
Platelet-activating factor receptor antagonist improves renal function and glomerular lesions in renal ablation.
Topics: Albuminuria; Animals; Azepines; Blood Pressure; Body Weight; Eicosanoids; Inulin; Kidney; Kidney Glomerulus; Male; Nephrectomy; Organ Size; p-Aminohippuric Acid; Platelet Activating Factor; Rats; Rats, Wistar; Triazoles | 1994 |
A 13-week toxicologic and pathologic evaluation of prolonged cytochromes P450 inhibition by 1-aminobenzotriazole in male rats.
Topics: Animals; Body Weight; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme Inhibitors; Eating; Liver; Male; Microsomes, Liver; Organ Size; Oxidoreductases; Rats; Rats, Inbred Strains; Triazoles | 1994 |
Interactions between the effects of basal forebrain lesions and chronic treatment with MDL 26,479 on learning and markers of cholinergic transmission.
Topics: Animals; Antidepressive Agents; Autoradiography; Biomarkers; Body Weight; Choline O-Acetyltransferase; Conditioning, Operant; Hemicholinium 3; Ibotenic Acid; Immunohistochemistry; Learning; Neuromuscular Depolarizing Agents; Parasympathetic Nervous System; Piperidines; Prosencephalon; Rats; Rats, Sprague-Dawley; Stereotaxic Techniques; Synaptic Transmission; Triazoles | 1993 |
The hypolipidemic effects of 1-acetyl-4-phenyl-1,2,4-triazolidine-3,5-dione in rodents.
Topics: Animals; Body Weight; Cholesterol; Diet; Eating; Feces; Hyperlipidemias; Hypolipidemic Agents; Intestine, Small; Lipid Metabolism; Lipoproteins; Liver; Male; Organ Size; Rats; Rats, Sprague-Dawley; Triazoles; Triglycerides | 1993 |
Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats.
Topics: Absorptiometry, Photon; Aging; Animals; Aromatase Inhibitors; Body Weight; Bone Density; Bone Development; Bone Remodeling; Enzyme Inhibitors; Femur; Insulin-Like Growth Factor I; Male; Orchiectomy; Rats; Rats, Wistar; Reference Values; Triazoles | 1997 |
Neonatal cerebral hypoxia-ischemia: the effect of adenosine receptor antagonists.
Topics: Animals; Animals, Newborn; Blood Gas Analysis; Blood Glucose; Body Temperature; Body Weight; Brain; Brain Ischemia; Cerebrovascular Circulation; Female; Hypoxia, Brain; Male; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Wistar; Receptor, Adenosine A2A; RNA, Messenger; Theophylline; Triazoles; Xanthines | 1997 |
The weanling male rat as an assay for endocrine disruption: preliminary observations.
Topics: Anastrozole; Androgen Antagonists; Animals; Body Weight; Cyproterone Acetate; Drug Evaluation, Preclinical; Endocrine System Diseases; Female; Lactose; Male; Methylcellulose; Nitriles; Organ Size; Oxazines; Oxazoles; Rats; Rats, Inbred Strains; Toxicology; Triazoles; Uterus; Weaning | 1997 |
Physiological plasma levels of androgens reduce bone loss in the ovariectomized rat.
Topics: Aging; Anastrozole; Androgen Antagonists; Androstenedione; Anilides; Animals; Body Weight; Bone Resorption; Enzyme Inhibitors; Estradiol; Female; Nitriles; Ovariectomy; Rats; Rats, Sprague-Dawley; Testosterone; Tosyl Compounds; Triazoles | 1998 |
In ovo treatment with an aromatase inhibitor masculinizes postnatal hormone levels, abdominal fat pad content, and GH pulsatility in broiler chickens.
Topics: Adipose Tissue; Analysis of Variance; Animals; Aromatase Inhibitors; Body Composition; Body Weight; Chick Embryo; Chickens; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Female; Growth Hormone; Injections; Male; Random Allocation; Sex Characteristics; Testosterone; Thyroxine; Time Factors; Triazoles; Triiodothyronine | 1998 |
Effects of demographic variables on vorozole pharmacokinetics in healthy volunteers and in breast cancer patients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Body Height; Body Weight; Breast Neoplasms; Female; Humans; Male; Middle Aged; Population; Regression Analysis; Sex Factors; Triazoles | 1998 |
Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer model.
Topics: Animals; Antineoplastic Agents; Aromatase Inhibitors; Body Weight; Carcinogens; Drug Administration Schedule; Drug Screening Assays, Antitumor; Estradiol; Estrus; Female; Genes, ras; Insulin-Like Growth Factor I; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Testosterone; Triazoles | 1998 |
Organizational effects of estrogens on brain vasotocin and sexual behavior in quail.
Topics: Analysis of Variance; Animals; Aromatase Inhibitors; Body Weight; Brain Chemistry; Cloaca; Coturnix; Embryo, Nonmammalian; Estradiol; Female; Immunohistochemistry; Male; Neurons; Preoptic Area; Sex Characteristics; Sexual Behavior, Animal; Testosterone; Triazoles; Vasotocin | 1998 |
The cytochrome P450 suicide inhibitor, 1-aminobenzotriazole, sensitizes rats to zymosan-induced toxicity.
Topics: Animals; Body Weight; Cytochrome P-450 Enzyme Inhibitors; Drug Synergism; Enzyme Inhibitors; Inflammation; Leukocyte Count; Male; Microsomes, Liver; Neutrophils; Nitrates; Nitrites; Organ Size; Rats; Rats, Sprague-Dawley; Survival Analysis; Triazoles; Zymosan | 1998 |
Single day treatment--a feasible tool in revealing not dependent on maternal toxicity teratogenic potential.
Topics: Abnormalities, Drug-Induced; Animals; Benomyl; Body Weight; Female; Plant Growth Regulators; Pregnancy; Rats; Rats, Wistar; Teratogens; Triazoles | 1998 |
Skeletal effects of estrogen deficiency as induced by an aromatase inhibitor in an aged male rat model.
Topics: Aging; Animals; Aromatase Inhibitors; Body Weight; Bone and Bones; Bone Density; Bone Remodeling; Enzyme Inhibitors; Estradiol; Estrogens; Male; Models, Animal; Rats; Rats, Wistar; Triazoles | 2000 |
Effect of citrate and aminotriazole on matrical plates induced in hepatic microbodies.
Topics: Amitrole; Animals; Aspirin; Body Weight; Carboxylic Acids; Catalase; Citrates; Clofibrate; Cyclopropanes; Esters; Inclusion Bodies; Ketoglutaric Acids; Liver; Methylation; Microbodies; Organ Size; Organoids; Propionates; Rats; Triazoles | 1975 |
Subacute toxicity of ethylenebisisothiocyanate sulfide in the laboratory rat.
Topics: Animals; Body Weight; Dermatitis; Diet; Dose-Response Relationship, Drug; Iodine Radioisotopes; Isothiocyanates; Methimazole; Organ Size; Rats; Thiocyanates; Thyroid Function Tests; Thyroxine; Triazoles; Triiodothyronine | 1977 |
[Toxicological studies on cefatrizine (S 640 P). 1. Acute toxicity, subacute toxicity in rats(author's transl)].
Topics: Acute Disease; Administration, Oral; Animals; Body Weight; Cephalosporins; Dogs; Drug Evaluation, Preclinical; Female; Injections, Intradermal; Injections, Intraperitoneal; Injections, Intravenous; Lethal Dose 50; Male; Mice; Rabbits; Rats; Triazoles | 1976 |
[Toxicological studies on cefatrizine (S-640 P). 3. Chronic toxicity in rats(author's transl)].
Topics: Administration, Oral; Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Urea Nitrogen; Body Weight; Bronchitis; Cephalosporins; Chronic Disease; Drinking; Drug Evaluation, Preclinical; Eating; Female; Lung; Male; Pneumonia; Rats; Triazoles | 1976 |
[Toxicological studies on cefatrizine (S-640 P). 2. Subacute toxicity in rats (author's transl)].
Topics: Administration, Oral; Animals; Body Weight; Cephalosporins; Drug Evaluation, Preclinical; Female; Liver; Lung; Male; Pulmonary Atelectasis; Rats; Time Factors; Triazoles | 1976 |
Chronic toxicity and carcinogenicity studies with FWAs.
Topics: Aging; Animals; Biphenyl Compounds; Body Weight; Carcinogens; Coloring Agents; Diet; Dogs; Female; Male; Organ Size; Rats; Species Specificity; Stilbenes; Triazoles | 1975 |
Three-generation Reproduction studies with FWAs.
Topics: Animals; Behavior, Animal; Biphenyl Compounds; Body Weight; Coloring Agents; Female; Male; Mice; Organ Size; Reproduction; Sexual Behavior, Animal; Stilbenes; Triazoles | 1975 |
Dapiprazol prevents U50,488H-mediated suppression of preparatory components of drinking behavior in rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenergic alpha-Antagonists; Animals; Body Weight; Depression, Chemical; Diuresis; Drinking Behavior; Male; Naloxone; Piperazines; Pyrrolidines; Rats; Rats, Inbred Strains; Triazoles | 1991 |
Endocrine and antitumoral effects of R76713 in rats.
Topics: Adrenal Cortex Hormones; Adrenal Glands; Animals; Antineoplastic Agents; Aromatase Inhibitors; Body Weight; Estradiol; Female; Luteinizing Hormone; Mammary Neoplasms, Experimental; Organ Size; Ovariectomy; Ovary; Progesterone; Rats; Rats, Inbred Strains; Triazoles; Uterus | 1990 |
A new non-hormonal antifertility drug DL 111-IT: I. Effects on testes and accessory glands of reproduction in male rats.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Animals; Body Weight; DNA; Epididymis; Genitalia, Male; Male; Organ Size; Prostate; Proteins; Rats; Rats, Inbred Strains; RNA; Seminal Vesicles; Sexual Maturation; Testis; Triazoles | 1986 |
[5-Substituted 3-mercapto-4H-1,2,4-triazoles as a potential thyrostaticagent].
Topics: Animals; Body Weight; Male; Organ Size; Rats; Rats, Inbred Strains; Sulfhydryl Compounds; Thyroid Gland; Thyroxine; Triazoles | 1989 |
Inhibition by 3-amino-1H-1,2,4-triazole of hepatic tumorigenesis induced by diethylstilbestrol alone or combined with N-nitrosobutylurea in WF rats.
Topics: Amitrole; Animals; Body Weight; Diethylstilbestrol; Liver Neoplasms; Male; Nitrosourea Compounds; Organ Size; Oxidation-Reduction; Pituitary Neoplasms; Rats; Rats, Inbred WF; Thyroid Gland; Triazoles | 1985 |
Effect of aminotriazole on thyroid function in the rat.
Topics: Amines; Animals; Body Weight; Iodine Radioisotopes; Male; Rats; Thyroid Function Tests; Thyroid Gland; Triazoles | 1968 |
Studies on regulatory aspects of nutrition at molecular level. I. Enzyme turnover during fasting.
Topics: Animals; Body Weight; Catalase; Depression, Chemical; Fasting; Kidney; Kinetics; Liver; Male; Nutritional Physiological Phenomena; Organ Size; Rats; Spectrophotometry; Starvation; Time Factors; Triazoles | 1968 |
Fetal uptake and embryogenetic effects of aminotriazole in mice.
Topics: Administration, Oral; Amitrole; Animals; Autoradiography; Body Weight; Bone Marrow; Carbon Radioisotopes; Chromatography, Thin Layer; Female; Fertility; Fetus; Gastric Mucosa; Gestational Age; Injections, Intravenous; Maternal-Fetal Exchange; Mice; Pregnancy; Spleen; Teratogens; Thymus Gland; Triazoles | 1974 |
Effect of carbon monoxide or of 3-aminotriazole on C-and N-hydroxylation of the carcinogen N-2-fluorenylacetamide by liver microsomes of hamsters pretreated with 3-methylcholanthrene.
Topics: Acetamides; Animals; Body Weight; Carbon Isotopes; Carbon Monoxide; Carcinogens; Chromatography, Paper; Cricetinae; Cytochrome P-450 Enzyme System; Fluorenes; Herbicides; Hydroxylation; Liver; Male; Methylcholanthrene; Microsomes, Liver; Organ Size; Triazoles | 1972 |
The toxicity of amitrole in the rat.
Topics: Amitrole; Animals; Body Weight; Diet; Female; Herbicides; Hyperplasia; Intubation, Gastrointestinal; Kidney; Liver; Male; Microscopy, Electron; Organ Size; Pyelonephritis; Rats; Reproduction; Sex Factors; Skin Diseases; Spleen; Thyroid Gland; Triazoles | 1973 |
The effect of ethyl-alpha-p-chlorophenoxisobutyrate (clofibrate) on alcohol metabolism.
Topics: Administration, Oral; Alcohol Oxidoreductases; Animals; Body Weight; Carbon Radioisotopes; Catalase; Clofibrate; Dinitrophenols; Ethanol; Female; In Vitro Techniques; Kinetics; Liver; Methanol; Microsomes, Liver; Organ Size; Oxidation-Reduction; Pyrazoles; Rats; Time Factors; Triazoles | 1973 |
Triamiphos: long-term toxicity and three-generation reproduction studies in rats.
Topics: Animals; Blood Cell Count; Body Weight; Brain; Cholinesterase Inhibitors; Cholinesterases; Dimethylamines; Eating; Erythrocytes; Female; Fertility; Germ-Free Life; Growth; Hemoglobins; Insecticides; Male; Neoplasms; Organ Size; Organophosphorus Compounds; Rats; Reproduction; Time Factors; Triazoles | 1974 |
Effect of reduced food intake on thyroid cell height and goitrogenic response in rats.
Topics: Animals; Body Weight; Drinking Behavior; Epithelial Cells; Food Deprivation; Goiter; Iodine Isotopes; Male; Organ Size; Rats; Thyroid Gland; Thyroid Hormones; Thyrotropin-Releasing Hormone; Triazoles | 1971 |
Carcinogen-mediated alteration of the rates of enzyme synthesis and degradation.
Topics: Animals; Body Weight; Carcinogens; Catalase; Kidney; Kinetics; Liver; Male; Rats; Triazoles | 1968 |
Studies on regulatory aspects of nutriton at molecular level. II. Enzyme turnover during protein deficiency.
Topics: Amides; Animals; Body Weight; Caseins; Catalase; Depression, Chemical; Diet; Kidney; Kinetics; Liver; Male; Mathematics; Molecular Biology; Nutritional Physiological Phenomena; Organ Size; Protein Deficiency; Time Factors; Triazoles | 1969 |
Aminotriazole, thyroid function, and catecholamines in nephrogenic hypertension in rats.
Topics: Adrenal Glands; Animals; Blood Pressure; Body Temperature; Body Weight; Epinephrine; Heart Rate; Hypertension, Renal; Hypothyroidism; Iodine; Male; Myocardium; Norepinephrine; Organ Size; Oxygen Consumption; Rats; Thyroid Gland; Triazoles | 1969 |